Saltar al contenido
Ver si califico
English

Cambios publicados y sus fechas

Consulta los cambios del registro, desde los requisitos de los programas hasta la cobertura de medicamentos. Cada entrada muestra la fecha y el cambio documentado.

Este es el historial de cambios que hemos publicado. No afirmamos haber registrado todos los cambios anteriores. Los ejemplos ilustrativos, cuando los hay, se identifican por separado.

El registro actual

Programas registrados
224
Fichas de programas verificadas
195
Medicamentos publicados
5,801
Relaciones entre medicamentos y programas
1,579
Información insuficiente
1,609

Estas cifras reflejan nuestro trabajo. No representan el total de programas de asistencia de Estados Unidos, ya que no existe un censo completo. Por qué no publicamos un total nacional

Historial de cambios

336 entradas publicadas. Informar de un error.

Los filtros indican el tema del cambio. Mostramos los valores anteriores y nuevos solo cuando se registraron por separado; en las demás entradas, consulta la descripción completa.

Las descripciones históricas sin traducción se muestran en su idioma original, inglés.

  1. Cambio en un programa

    AadiAssist Patient Assistance Program

    Qué cambió

    FYARRO is covered by AadiAssist Patient Assistance Program.

    Fuente

    Entrada histórica.

  2. Cambio en un programa

    AadiAssist Patient Assistance Program

    Qué cambió

    AadiAssist Patient Assistance Program is now listed. It provides the medicine at no cost to patients who qualify.

    Fuente

    Entrada histórica.

  3. Cambio en un programa

    AccordCares: Camcevi

    Qué cambió

    CAMCEVI is covered by AccordCares: Camcevi.

    Fuente

    Entrada histórica.

  4. Cambio en un programa

    AccordCares: Camcevi

    Qué cambió

    AccordCares: Camcevi is now listed. The program's own pages do not say whether the medicine is free — check the application for details.

    Fuente

    Entrada histórica.

  5. Cambio en un programa

    AccordCares: Hercessi

    Qué cambió

    HERCESSI is covered by AccordCares: Hercessi.

    Fuente

    Entrada histórica.

  6. Cambio en un programa

    AccordCares: Hercessi

    Qué cambió

    AccordCares: Hercessi is now listed. The program's own pages do not say whether the medicine is free — check the application for details.

    Fuente

    Entrada histórica.

  7. Cambio en un programa

    AdaptimmuneAssist

    Qué cambió

    TECELRA is covered by AdaptimmuneAssist.

    Fuente

    Entrada histórica.

  8. Cambio en un programa

    AdaptimmuneAssist

    Qué cambió

    AdaptimmuneAssist is now listed. The program's own pages do not say whether the medicine is free — check the application for details.

    Fuente

    Entrada histórica.

  9. Cambio en un programa

    Advancing Patient Support: Zynlonta

    Qué cambió

    ZYNLONTA is covered by Advancing Patient Support: Zynlonta.

    Fuente

    Entrada histórica.

  10. Cambio en un programa

    Advancing Patient Support: Zynlonta

    Qué cambió

    Advancing Patient Support: Zynlonta is now listed. The program's own pages do not say whether the medicine is free — check the application for details.

    Fuente

    Entrada histórica.

  11. Cambio en un programa

    Alnylam Assist: AMVUTTRA

    Qué cambió

    AMVUTTRA is covered by Alnylam Assist: AMVUTTRA.

    Fuente

    Entrada histórica.

  12. Cambio en un programa

    Alnylam Assist: AMVUTTRA

    Qué cambió

    Alnylam Assist: AMVUTTRA is now listed. It provides the medicine at no cost to patients who qualify.

    Fuente

    Entrada histórica.

  13. Cambio en un programa

    Alnylam Assist: GIVLAARI

    Qué cambió

    GIVLAARI is covered by Alnylam Assist: GIVLAARI.

    Fuente

    Entrada histórica.

  14. Cambio en un programa

    Alnylam Assist: GIVLAARI

    Qué cambió

    Alnylam Assist: GIVLAARI is now listed. It provides the medicine at no cost to patients who qualify.

    Fuente

    Entrada histórica.

  15. Cambio en un programa

    Alnylam Assist: ONPATTRO

    Qué cambió

    ONPATTRO is covered by Alnylam Assist: ONPATTRO.

    Fuente

    Entrada histórica.

  16. Cambio en un programa

    Alnylam Assist: ONPATTRO

    Qué cambió

    Alnylam Assist: ONPATTRO is now listed. It provides the medicine at no cost to patients who qualify.

    Fuente

    Entrada histórica.

  17. Cambio en un programa

    Alnylam Assist: OXLUMO

    Qué cambió

    OXLUMO is covered by Alnylam Assist: OXLUMO.

    Fuente

    Entrada histórica.

  18. Cambio en un programa

    Alnylam Assist: OXLUMO

    Qué cambió

    Alnylam Assist: OXLUMO is now listed. It provides the medicine at no cost to patients who qualify.

    Fuente

    Entrada histórica.

  19. Cambio en un programa

    Amicus Assist: Galafold

    Qué cambió

    Amicus Assist: Galafold is now listed. It provides the medicine at no cost to patients who qualify.

    Fuente

    Entrada histórica.

  20. Cambio en un programa

    Amicus Assist: Pombiliti + Opfolda

    Qué cambió

    Amicus Assist: Pombiliti + Opfolda is now listed. It provides the medicine at no cost to patients who qualify.

    Fuente

    Entrada histórica.

  21. Cambio en un programa

    Andembry Connect

    Qué cambió

    Andembry is covered by Andembry Connect.

    Fuente

    Entrada histórica.

  22. Cambio en un programa

    Andembry Connect

    Qué cambió

    Andembry Connect is now listed. It provides the medicine at no cost to patients who qualify.

    Fuente

    Entrada histórica.

  23. Cambio en un programa

    ApellisAssist: Empaveli

    Qué cambió

    Empaveli is covered by ApellisAssist: Empaveli.

    Fuente

    Entrada histórica.

  24. Cambio en un programa

    ApellisAssist: Empaveli

    Qué cambió

    ApellisAssist: Empaveli is now listed. It provides the medicine at no cost to patients who qualify.

    Fuente

    Entrada histórica.

  25. Cambio en un programa

    Aquoral Assistance Program

    Qué cambió

    Aquoral is covered by Aquoral Assistance Program.

    Fuente

    Entrada histórica.

  26. Cambio en un programa

    Aquoral Assistance Program

    Qué cambió

    Aquoral Assistance Program is now listed. The program's own pages do not say whether the medicine is free — check the application for details.

    Fuente

    Entrada histórica.

  27. Cambio en un programa

    Aristada Care Support

    Qué cambió

    Aristada is covered by Aristada Care Support.

    Fuente

    Entrada histórica.

  28. Cambio en un programa

    Aristada Care Support

    Qué cambió

    Aristada Initio is covered by Aristada Care Support.

    Fuente

    Entrada histórica.

  29. Cambio en un programa

    Aristada Care Support

    Qué cambió

    Aristada Care Support is now listed. It provides the medicine at no cost to patients who qualify.

    Fuente

    Entrada histórica.

  30. Cambio en un programa

    Ascendis Signature Access Program (A.S.A.P): Yorvipath

    Qué cambió

    Yorvipath is covered by Ascendis Signature Access Program (A.S.A.P): Yorvipath.

    Fuente

    Entrada histórica.

  31. Cambio en un programa

    Ascendis Signature Access Program (A.S.A.P): Yorvipath

    Qué cambió

    Ascendis Signature Access Program (A.S.A.P): Yorvipath is now listed. It provides the medicine at no cost to patients who qualify.

    Fuente

    Entrada histórica.

  32. Cambio en un programa

    Ascendis Signature Access Program (A.S.A.P): Yuviwel

    Qué cambió

    Yuviwel is covered by Ascendis Signature Access Program (A.S.A.P): Yuviwel.

    Fuente

    Entrada histórica.

  33. Cambio en un programa

    Ascendis Signature Access Program (A.S.A.P): Yuviwel

    Qué cambió

    Ascendis Signature Access Program (A.S.A.P): Yuviwel is now listed. It provides the medicine at no cost to patients who qualify.

    Fuente

    Entrada histórica.

  34. Cambio en un programa

    Aucta Patient Assistance Program (PAP)

    Qué cambió

    MOTPOLY XR is covered by Aucta Patient Assistance Program (PAP).

    Fuente

    Entrada histórica.

  35. Cambio en un programa

    Aucta Patient Assistance Program (PAP)

    Qué cambió

    Aucta Patient Assistance Program (PAP) is now listed. The program's own pages do not say whether the medicine is free — check the application for details.

    Fuente

    Entrada histórica.

  36. Cambio en un programa

    Aveo ACE (Access Center of Excellence)

    Qué cambió

    FOTIVDA is covered by Aveo ACE (Access Center of Excellence).

    Fuente

    Entrada histórica.

  37. Cambio en un programa

    Aveo ACE (Access Center of Excellence)

    Qué cambió

    Aveo ACE (Access Center of Excellence) is now listed. It provides the medicine at no cost to patients who qualify.

    Fuente

    Entrada histórica.

  38. Cambio en un programa

    Biocon Biologics Patient Assistance Program

    Qué cambió

    Yesintek is covered by Biocon Biologics Patient Assistance Program.

    Fuente

    Entrada histórica.

  39. Cambio en un programa

    Biocon Biologics Patient Assistance Program

    Qué cambió

    Adalimumab-fkjp is covered by Biocon Biologics Patient Assistance Program.

    Fuente

    Entrada histórica.

  40. Cambio en un programa

    Biocon Biologics Patient Assistance Program

    Qué cambió

    Insulin Glargine-yfgn is covered by Biocon Biologics Patient Assistance Program.

    Fuente

    Entrada histórica.

  41. Cambio en un programa

    Biocon Biologics Patient Assistance Program

    Qué cambió

    Jobevne is covered by Biocon Biologics Patient Assistance Program.

    Fuente

    Entrada histórica.

  42. Cambio en un programa

    Biocon Biologics Patient Assistance Program

    Qué cambió

    Kirsty is covered by Biocon Biologics Patient Assistance Program.

    Fuente

    Entrada histórica.

  43. Cambio en un programa

    Biocon Biologics Patient Assistance Program

    Qué cambió

    Bosaya/Aukelso is covered by Biocon Biologics Patient Assistance Program.

    Fuente

    Entrada histórica.

  44. Cambio en un programa

    Biocon Biologics Patient Assistance Program

    Qué cambió

    Biocon Biologics Patient Assistance Program is now listed. It provides the medicine at no cost to patients who qualify.

    Fuente

    Entrada histórica.

  45. Cambio en un programa

    Bristol-Myers Squibb Destination Access Patient Assistance program for Ixempra

    Qué cambió

    Ixempra is covered by Bristol-Myers Squibb Destination Access Patient Assistance program for Ixempra.

    Fuente

    Entrada histórica.

  46. Cambio en un programa

    Bristol-Myers Squibb Destination Access Patient Assistance program for Ixempra

    Qué cambió

    Bristol-Myers Squibb Destination Access Patient Assistance program for Ixempra is now listed. The program's own pages do not say whether the medicine is free — check the application for details.

    Fuente

    Entrada histórica.

  47. Cambio en un programa

    BRIUMVI Patient Support

    Qué cambió

    BRIUMVI is covered by BRIUMVI Patient Support.

    Fuente

    Entrada histórica.

  48. Cambio en un programa

    BRIUMVI Patient Support

    Qué cambió

    BRIUMVI Patient Support is now listed. The program's own pages do not say whether the medicine is free — check the application for details.

    Fuente

    Entrada histórica.

  49. Cambio en un programa

    Buphenyl Drug Assistance Program

    Qué cambió

    Pheburane is covered by Buphenyl Drug Assistance Program.

    Fuente

    Entrada histórica.

  50. Cambio en un programa

    Buphenyl Drug Assistance Program

    Qué cambió

    Buphenyl Drug Assistance Program is now listed. It provides the medicine at no cost to patients who qualify.

    Fuente

    Entrada histórica.

  51. Cambio en un programa

    Caprelsa Patient Assistance Program

    Qué cambió

    Caprelsa is covered by Caprelsa Patient Assistance Program.

    Fuente

    Entrada histórica.

  52. Cambio en un programa

    Caprelsa Patient Assistance Program

    Qué cambió

    Caprelsa Patient Assistance Program is now listed. It provides the medicine at no cost to patients who qualify.

    Fuente

    Entrada histórica.

  53. Cambio en un programa

    CareASSIST Patient Assistance Program

    Qué cambió

    SARCLISA is covered by CareASSIST Patient Assistance Program.

    Fuente

    Entrada histórica.

  54. Cambio en un programa

    CareASSIST Patient Assistance Program

    Qué cambió

    SARCLISA ESCENA is covered by CareASSIST Patient Assistance Program.

    Fuente

    Entrada histórica.

  55. Cambio en un programa

    CareASSIST Patient Assistance Program

    Qué cambió

    CareASSIST Patient Assistance Program is now listed. It provides the medicine at no cost to patients who qualify.

    Fuente

    Entrada histórica.

  56. Cambio en un programa

    Cayston Patient Assistance Program

    Qué cambió

    CAYSTON is covered by Cayston Patient Assistance Program.

    Fuente

    Entrada histórica.

  57. Cambio en un programa

    Cayston Patient Assistance Program

    Qué cambió

    ALTERA Nebulizer System is covered by Cayston Patient Assistance Program.

    Fuente

    Entrada histórica.

  58. Cambio en un programa

    Cayston Patient Assistance Program

    Qué cambió

    Cayston Patient Assistance Program is now listed. The program's own pages do not say whether the medicine is free — check the application for details.

    Fuente

    Entrada histórica.

  59. Cambio en un programa

    Celltrion CONNECT Steqeyma Patient Assistance Program

    Qué cambió

    STEQEYMA is covered by Celltrion CONNECT Steqeyma Patient Assistance Program.

    Fuente

    Entrada histórica.

  60. Cambio en un programa

    Celltrion CONNECT Steqeyma Patient Assistance Program

    Qué cambió

    Celltrion CONNECT Steqeyma Patient Assistance Program is now listed. It provides the medicine at no cost to patients who qualify.

    Fuente

    Entrada histórica.

  61. Cambio en un programa

    Celltrion CONNECT: Adalimumab-aaty Patient Assistance Program

    Qué cambió

    Adalimumab-aaty is covered by Celltrion CONNECT: Adalimumab-aaty Patient Assistance Program.

    Fuente

    Entrada histórica.

  62. Cambio en un programa

    Celltrion CONNECT: Adalimumab-aaty Patient Assistance Program

    Qué cambió

    Celltrion CONNECT: Adalimumab-aaty Patient Assistance Program is now listed. It provides the medicine at no cost to patients who qualify.

    Fuente

    Entrada histórica.

  63. Cambio en un programa

    Celltrion CONNECT: Avtozma Patient Assistance Program

    Qué cambió

    AVTOZMA is covered by Celltrion CONNECT: Avtozma Patient Assistance Program.

    Fuente

    Entrada histórica.

  64. Cambio en un programa

    Celltrion CONNECT: Avtozma Patient Assistance Program

    Qué cambió

    Celltrion CONNECT: Avtozma Patient Assistance Program is now listed. It provides the medicine at no cost to patients who qualify.

    Fuente

    Entrada histórica.

  65. Cambio en un programa

    Celltrion CONNECT: Osenvelt Patient Assistance Program

    Qué cambió

    OSENVELT is covered by Celltrion CONNECT: Osenvelt Patient Assistance Program.

    Fuente

    Entrada histórica.

  66. Cambio en un programa

    Celltrion CONNECT: Osenvelt Patient Assistance Program

    Qué cambió

    Celltrion CONNECT: Osenvelt Patient Assistance Program is now listed. It provides the medicine at no cost to patients who qualify.

    Fuente

    Entrada histórica.

  67. Cambio en un programa

    Celltrion CONNECT: Stoboclo Patient Assistance Program

    Qué cambió

    Stoboclo is covered by Celltrion CONNECT: Stoboclo Patient Assistance Program.

    Fuente

    Entrada histórica.

  68. Cambio en un programa

    Celltrion CONNECT: Stoboclo Patient Assistance Program

    Qué cambió

    Celltrion CONNECT: Stoboclo Patient Assistance Program is now listed. The program's own pages do not say whether the medicine is free — check the application for details.

    Fuente

    Entrada histórica.

  69. Cambio en un programa

    Celltrion CONNECT: Vegzelma Patient Assistance Program

    Qué cambió

    Vegzelma is covered by Celltrion CONNECT: Vegzelma Patient Assistance Program.

    Fuente

    Entrada histórica.

  70. Cambio en un programa

    Celltrion CONNECT: Vegzelma Patient Assistance Program

    Qué cambió

    Celltrion CONNECT: Vegzelma Patient Assistance Program is now listed. The program's own pages do not say whether the medicine is free — check the application for details.

    Fuente

    Entrada histórica.

  71. Cambio en un programa

    Celltrion CONNECT: Zymfentra Patient Assistance Program

    Qué cambió

    Zymfentra is covered by Celltrion CONNECT: Zymfentra Patient Assistance Program.

    Fuente

    Entrada histórica.

  72. Cambio en un programa

    Celltrion CONNECT: Zymfentra Patient Assistance Program

    Qué cambió

    Celltrion CONNECT: Zymfentra Patient Assistance Program is now listed. The program's own pages do not say whether the medicine is free — check the application for details.

    Fuente

    Entrada histórica.

  73. Cambio en un programa

    ChimerixCares

    Qué cambió

    We updated our verified record for ChimerixCares.

    Fuente

    Entrada histórica.

  74. Cambio en un programa

    ChimerixCares

    Qué cambió

    ChimerixCares is now listed. It provides the medicine at no cost to patients who qualify.

    Fuente

    Entrada histórica.

  75. Cambio en un programa

    CoverOne Program: Bavencio

    Qué cambió

    CoverOne Program: Bavencio is now listed. It provides the medicine at no cost to patients who qualify.

    Fuente

    Entrada histórica.

  76. Cambio en un programa

    CrinetiCARE Patient Assistance Program

    Qué cambió

    PALSONIFY is covered by CrinetiCARE Patient Assistance Program.

    Fuente

    Entrada histórica.

  77. Cambio en un programa

    CrinetiCARE Patient Assistance Program

    Qué cambió

    CrinetiCARE Patient Assistance Program is now listed. It provides the medicine at no cost to patients who qualify.

    Fuente

    Entrada histórica.

  78. Cambio en un programa

    Cystadane Patient Assistance Program

    Qué cambió

    CYSTADANE is covered by Cystadane Patient Assistance Program.

    Fuente

    Entrada histórica.

  79. Cambio en un programa

    Cystadane Patient Assistance Program

    Qué cambió

    Cystadane Patient Assistance Program is now listed. The program's own pages do not say whether the medicine is free — check the application for details.

    Fuente

    Entrada histórica.

  80. Cambio en un programa

    Cystatdane Patient Assistance Program

    Qué cambió

    Cystatdane Patient Assistance Program is now listed. The program's own pages do not say whether the medicine is free — check the application for details.

    Fuente

    Entrada histórica.

  81. Cambio en un programa

    Danziten CONNECT

    Qué cambió

    Danziten CONNECT is now listed. It provides the medicine at no cost to patients who qualify.

    Fuente

    Entrada histórica.

  82. Cambio en un programa

    Daraprim Direct Program

    Qué cambió

    DARAPRIM is covered by Daraprim Direct Program.

    Fuente

    Entrada histórica.

  83. Cambio en un programa

    Daraprim Direct Program

    Qué cambió

    Daraprim Direct Program is now listed. It provides the medicine at no cost to patients who qualify.

    Fuente

    Entrada histórica.

  84. Cambio en un programa

    Datroway 4U Patient Assistance Program

    Qué cambió

    Datroway 4U Patient Assistance Program is now listed. The program's own pages do not say whether the medicine is free — check the application for details.

    Fuente

    Entrada histórica.

  85. Cambio en un programa

    Deciphera AccessPoint: Qinlock

    Qué cambió

    QINLOCK is covered by Deciphera AccessPoint: Qinlock.

    Fuente

    Entrada histórica.

  86. Cambio en un programa

    Deciphera AccessPoint: Qinlock

    Qué cambió

    Deciphera AccessPoint: Qinlock is now listed. The program's own pages do not say whether the medicine is free — check the application for details.

    Fuente

    Entrada histórica.

  87. Cambio en un programa

    Deciphera AccessPoint: Romvimza

    Qué cambió

    ROMVIMZA is covered by Deciphera AccessPoint: Romvimza.

    Fuente

    Entrada histórica.

  88. Cambio en un programa

    Deciphera AccessPoint: Romvimza

    Qué cambió

    Deciphera AccessPoint: Romvimza is now listed. The program's own pages do not say whether the medicine is free — check the application for details.

    Fuente

    Entrada histórica.

  89. Cambio en un programa

    Dexcom Patient Assistance Program

    Qué cambió

    Dexcom Patient Assistance Program is now listed. The program's own pages do not say whether the medicine is free — check the application for details.

    Fuente

    Entrada histórica.

  90. Cambio en un programa

    Dupixent MyWay Program

    Qué cambió

    Dupixent is covered by Dupixent MyWay Program.

    Fuente

    Entrada histórica.

  91. Cambio en un programa

    Dupixent MyWay Program

    Qué cambió

    Dupixent MyWay Program is now listed. The program's own pages do not say whether the medicine is free — check the application for details.

    Fuente

    Entrada histórica.

  92. Cambio en un programa

    EpiPen4School Program

    Qué cambió

    EPIPEN is covered by EpiPen4School Program.

    Fuente

    Entrada histórica.

  93. Cambio en un programa

    EpiPen4School Program

    Qué cambió

    EPIPEN JR is covered by EpiPen4School Program.

    Fuente

    Entrada histórica.

  94. Cambio en un programa

    EpiPen4School Program

    Qué cambió

    authorized generic versions of EPIPEN and EPIPEN JR is covered by EpiPen4School Program.

    Fuente

    Entrada histórica.

  95. Cambio en un programa

    EpiPen4School Program

    Qué cambió

    EpiPen4School Program is now listed. The program's own pages do not say whether the medicine is free — check the application for details.

    Fuente

    Entrada histórica.

  96. Cambio en un programa

    Equetro Patient Assistance Program

    Qué cambió

    Equetro is covered by Equetro Patient Assistance Program.

    Fuente

    Entrada histórica.

  97. Cambio en un programa

    Equetro Patient Assistance Program

    Qué cambió

    Equetro Patient Assistance Program is now listed. It provides the medicine at no cost to patients who qualify.

    Fuente

    Entrada histórica.

  98. Cambio en un programa

    EveryDay Support From Day One

    Qué cambió

    OJEMDA is covered by EveryDay Support From Day One.

    Fuente

    Entrada histórica.

  99. Cambio en un programa

    EveryDay Support From Day One

    Qué cambió

    EveryDay Support From Day One is now listed. The program's own pages do not say whether the medicine is free — check the application for details.

    Fuente

    Entrada histórica.

  100. Cambio en un programa

    ForgingBridges Support Program

    Qué cambió

    Attruby is covered by ForgingBridges Support Program.

    Fuente

    Entrada histórica.

  101. Cambio en un programa

    ForgingBridges Support Program

    Qué cambió

    ForgingBridges Support Program is now listed. It provides the medicine at no cost to patients who qualify.

    Fuente

    Entrada histórica.

  102. Cambio en un programa

    Ipsen Cares Program: Bylvay

    Qué cambió

    Ipsen Cares Program: Bylvay is now listed. It provides the medicine at no cost to patients who qualify.

    Fuente

    Entrada histórica.

  103. Cambio en un programa

    HarborPath Oncology Patient Assistance Program

    Qué cambió

    HarborPath Oncology Patient Assistance Program is now listed. The program's own pages do not say whether the medicine is free — check the application for details.

    Fuente

    Entrada histórica.

  104. Cambio en un programa

    HetliozSolutions

    Qué cambió

    We updated our verified record for HetliozSolutions.

    Fuente

    Entrada histórica.

  105. Cambio en un programa

    HetliozSolutions

    Qué cambió

    HetliozSolutions is now listed. It provides the medicine at no cost to patients who qualify.

    Fuente

    Entrada histórica.

  106. Cambio en un programa

    Gamunex Connexions

    Qué cambió

    GAMUNEX-C is covered by Gamunex Connexions.

    Fuente

    Entrada histórica.

  107. Cambio en un programa

    Gamunex Connexions

    Qué cambió

    Gamunex Connexions is now listed. The program's own pages do not say whether the medicine is free — check the application for details.

    Fuente

    Entrada histórica.

  108. Cambio en un programa

    HemAssist Sanofi Support

    Qué cambió

    HemAssist Sanofi Support is now listed. The program's own pages do not say whether the medicine is free — check the application for details.

    Fuente

    Entrada histórica.

  109. Cambio en un programa

    Gamifant Cares

    Qué cambió

    We updated our verified record for Gamifant Cares.

    Fuente

    Entrada histórica.

  110. Cambio en un programa

    Gamifant Cares

    Qué cambió

    Gamifant Cares is now listed. It provides the medicine at no cost to patients who qualify.

    Fuente

    Entrada histórica.

  111. Cambio en un programa

    Ligand Assistance Program

    Qué cambió

    Ontak is covered by Ligand Assistance Program.

    Fuente

    Entrada histórica.

  112. Cambio en un programa

    Ligand Assistance Program

    Qué cambió

    Panretin Gel is covered by Ligand Assistance Program.

    Fuente

    Entrada histórica.

  113. Cambio en un programa

    Ligand Assistance Program

    Qué cambió

    Ligand Assistance Program is now listed. The program's own pages do not say whether the medicine is free — check the application for details.

    Fuente

    Entrada histórica.

  114. Cambio en un programa

    ITF ARC

    Qué cambió

    We updated our verified record for ITF ARC.

    Fuente

    Entrada histórica.

  115. Cambio en un programa

    ITF ARC

    Qué cambió

    ITF ARC is now listed. It provides the medicine at no cost to patients who qualify.

    Fuente

    Entrada histórica.

  116. Cambio en un programa

    GSK Vaccines Access Program

    Qué cambió

    AREXVY is covered by GSK Vaccines Access Program.

    Fuente

    Entrada histórica.

  117. Cambio en un programa

    GSK Vaccines Access Program

    Qué cambió

    BOOSTRIX is covered by GSK Vaccines Access Program.

    Fuente

    Entrada histórica.

  118. Cambio en un programa

    GSK Vaccines Access Program

    Qué cambió

    ENGERIX-B is covered by GSK Vaccines Access Program.

    Fuente

    Entrada histórica.

  119. Cambio en un programa

    GSK Vaccines Access Program

    Qué cambió

    SHINGRIX is covered by GSK Vaccines Access Program.

    Fuente

    Entrada histórica.

  120. Cambio en un programa

    GSK Vaccines Access Program

    Qué cambió

    GSK Vaccines Access Program is now listed. The program's own pages do not say whether the medicine is free — check the application for details.

    Fuente

    Entrada histórica.

  121. Cambio en un programa

    Sucraid Patient Assistance Program

    Qué cambió

    Sucraid is covered by Sucraid Patient Assistance Program.

    Fuente

    Entrada histórica.

  122. Cambio en un programa

    Sucraid Patient Assistance Program

    Qué cambió

    Sucraid Patient Assistance Program is now listed. The program's own pages do not say whether the medicine is free — check the application for details.

    Fuente

    Entrada histórica.

  123. Cambio en un programa

    WinRho Patient Assistance Program

    Qué cambió

    WinRho Patient Assistance Program is now listed. The program's own pages do not say whether the medicine is free — check the application for details.

    Fuente

    Entrada histórica.

  124. Cambio en un programa

    Zyflo Connect Patient Assistance Program

    Qué cambió

    Zyflo Connect Patient Assistance Program is now listed. The program's own pages do not say whether the medicine is free — check the application for details.

    Fuente

    Entrada histórica.

  125. Cambio en un programa

    Recordati Reimbursement Hotline

    Qué cambió

    Carbaglu is covered by Recordati Reimbursement Hotline.

    Fuente

    Entrada histórica.

  126. Cambio en un programa

    Recordati Reimbursement Hotline

    Qué cambió

    Recordati Reimbursement Hotline is now listed. The program's own pages do not say whether the medicine is free — check the application for details.

    Fuente

    Entrada histórica.

  127. Cambio en el registro

    Qué cambió

    Removed a listing whose medicine name and ingredient did not match (Gris-PEG was listed with the wrong ingredients). This was a data error on our side, not a change to any assistance program.

    Fuente

    Entrada histórica.

  128. Cambio en el registro

    Qué cambió

    Removed a listing whose medicine name and ingredient did not match (BSS Ophthalmic Solution was listed with the wrong ingredients). This was a data error on our side, not a change to any assistance program.

    Fuente

    Entrada histórica.

  129. Cambio en el registro

    Qué cambió

    Removed a listing whose medicine name and ingredient did not match (Doctor's Choice was listed with the wrong ingredients). This was a data error on our side, not a change to any assistance program.

    Fuente

    Entrada histórica.

  130. Cambio en el registro

    Qué cambió

    Removed a listing whose medicine name and ingredient did not match (MTX Support was listed with the wrong ingredients). This was a data error on our side, not a change to any assistance program.

    Fuente

    Entrada histórica.

  131. Cambio en el registro

    Qué cambió

    Removed a listing whose medicine name and ingredient did not match (Procto-Kit was listed with the wrong ingredients). This was a data error on our side, not a change to any assistance program.

    Fuente

    Entrada histórica.

  132. Cambio en el registro

    Qué cambió

    Removed a listing whose medicine name and ingredient did not match (Gas-X Prevention was listed with the wrong ingredients). This was a data error on our side, not a change to any assistance program.

    Fuente

    Entrada histórica.

  133. Cambio en el registro

    Qué cambió

    Removed a listing whose medicine name and ingredient did not match (Gaviscon Chewable was listed with the wrong ingredients). This was a data error on our side, not a change to any assistance program.

    Fuente

    Entrada histórica.

  134. Cambio en el registro

    Qué cambió

    Removed a listing whose medicine name and ingredient did not match (Maalox Max was listed with the wrong ingredients). This was a data error on our side, not a change to any assistance program.

    Fuente

    Entrada histórica.

  135. Cambio en el registro

    Qué cambió

    Removed a listing whose medicine name and ingredient did not match (Neo-Synephrine 12 Hour was listed with the wrong ingredients). This was a data error on our side, not a change to any assistance program.

    Fuente

    Entrada histórica.

  136. Cambio en el registro

    Qué cambió

    Removed a listing whose medicine name and ingredient did not match (Humalog Mix was listed with the wrong ingredients). This was a data error on our side, not a change to any assistance program.

    Fuente

    Entrada histórica.

  137. Cambio en el registro

    Qué cambió

    Removed a listing whose medicine name and ingredient did not match (Dialyvite Vitamin D3 Max was listed with the wrong ingredients). This was a data error on our side, not a change to any assistance program.

    Fuente

    Entrada histórica.

  138. Cambio en el registro

    Qué cambió

    Isopto Carbachol was listed under atropine by mistake. The two medicines do opposite things to the eye, so we removed the incorrect name. Isopto Atropine's listing is unchanged.

    Fuente

    Entrada histórica.

  139. Cambio en el registro

    Qué cambió

    Noven Pharmaceuticals states on its own site that it does not have a patient assistance program. Its four medicines are listed as not covered rather than left unanswered.

    Fuente

    Entrada histórica.

  140. Cambio en el registro

    Qué cambió

    Zydus says on its own site that it does not run patient assistance programs for its generic medicines. Its four generic medicines are now listed as not covered instead of unanswered.

    Fuente

    Entrada histórica.

  141. Cambio en el registro

    Qué cambió

    Checked 59 medicines against Viatris's and Amgen's own published assistance lists: 12 are on a list and 47 are not. Both answers are now shown with a link to the list we read.

    Fuente

    Entrada histórica.

  142. Cambio en un programa

    Mission Pharmaceutical Patient Assistance Program

    Qué cambió

    We could not confirm that Mission Pharmacal offers free medicine. Its website has no patient assistance page, and the only help it advertises is a savings card for people with commercial insurance. We no longer show this as a free-medicine program.

    Fuente

    Entrada histórica.

  143. Cambio en un programa

    Gilead Advancing Access

    Qué cambió

    Gilead's assistance program does not publish a fixed list of covered medicines -- its application asks you to write in the medicine you were prescribed. We now say so plainly instead of implying we checked a list.

    Fuente

    Entrada histórica.

  144. Cambio en un programa

    Carnitor Drug Assistance Program

    Qué cambió

    The Carnitor assistance program takes applications by phone and mail and does not publish a list of covered forms of the medicine online. We now say that instead of leaving these entries looking unchecked.

    Fuente

    Entrada histórica.

  145. Cambio en un programa

    Gilead Advancing Access

    Qué cambió

    Sunlenca's coverage under Gilead's program is based on Gilead's own statement that it supplies prescribed Gilead medicines, not on a published list of covered medicines. We have relabelled it so the evidence behind it is described accurately.

    Fuente

    Entrada histórica.

  146. Cambio en el registro

    Qué cambió

    Checked 173 medicines against the assistance lists of their makers. 69 are named on a program's list and 44 are not. Gilead's and Leadiant's programs publish no list at all, so their medicines are marked as unanswerable from a list rather than as refused.

    Fuente

    Entrada histórica.

  147. Cambio en un programa

    ILUMYA Support Patient Assistance Program

    Qué cambió

    Added ILUMYA Support Patient Assistance Program. The company's own materials say eligible patients can get the medicine at no cost; we quote that sentence and link to the page we read. Still marked unverified until a second reader checks it.

    Fuente

    Entrada histórica.

  148. Cambio en un programa

    Cortrophin Gel In Your Corner Patient Assistance Program

    Qué cambió

    Added Cortrophin Gel In Your Corner Patient Assistance Program. The company's own materials say eligible patients can get the medicine at no cost; we quote that sentence and link to the page we read. Still marked unverified until a second reader checks it.

    Fuente

    Entrada histórica.

  149. Cambio en un programa

    Tolmar Patient Assistance Program (Fensolvi Total Solutions)

    Qué cambió

    Added Tolmar Patient Assistance Program (Fensolvi Total Solutions). The company's own materials say eligible patients can get the medicine at no cost; we quote that sentence and link to the page we read. Still marked unverified until a second reader checks it.

    Fuente

    Entrada histórica.

  150. Cambio en un programa

    Xeris Patient Assistance Program (Gvoke)

    Qué cambió

    Added Xeris Patient Assistance Program (Gvoke). The company's own materials say eligible patients can get the medicine at no cost; we quote that sentence and link to the page we read. Still marked unverified until a second reader checks it.

    Fuente

    Entrada histórica.

  151. Cambio en un programa

    Gocovri Patient Assistance Program

    Qué cambió

    Added Gocovri Patient Assistance Program. The company's own materials say eligible patients can get the medicine at no cost; we quote that sentence and link to the page we read. Still marked unverified until a second reader checks it.

    Fuente

    Entrada histórica.

  152. Cambio en un programa

    LIFYORLI Support Patient Assistance Program

    Qué cambió

    Added LIFYORLI Support Patient Assistance Program. The company's own materials say eligible patients can get the medicine at no cost; we quote that sentence and link to the page we read. Still marked unverified until a second reader checks it.

    Fuente

    Entrada histórica.

  153. Cambio en un programa

    Gleostine Patient Assistance Program (Patient Lynx Support)

    Qué cambió

    Added Gleostine Patient Assistance Program (Patient Lynx Support). The company's own materials say eligible patients can get the medicine at no cost; we quote that sentence and link to the page we read. Still marked unverified until a second reader checks it.

    Fuente

    Entrada histórica.

  154. Cambio en un programa

    pharma& Patient Assistance Program (Rubraca)

    Qué cambió

    Added pharma& Patient Assistance Program (Rubraca). The company's own materials say eligible patients can get the medicine at no cost; we quote that sentence and link to the page we read. Still marked unverified until a second reader checks it.

    Fuente

    Entrada histórica.

  155. Cambio en un programa

    Inbrija Patient Assistance Program

    Qué cambió

    Added Inbrija Patient Assistance Program. The company's own materials say eligible patients can get the medicine at no cost; we quote that sentence and link to the page we read. Still marked unverified until a second reader checks it.

    Fuente

    Entrada histórica.

  156. Cambio en un programa

    MS LifeLines Patient Assistance Program (Rebif)

    Qué cambió

    Added MS LifeLines Patient Assistance Program (Rebif). The company's own materials say eligible patients can get the medicine at no cost; we quote that sentence and link to the page we read. Still marked unverified until a second reader checks it.

    Fuente

    Entrada histórica.

  157. Cambio en el registro

    Qué cambió

    Checked 187 medicines from the wave-G3 review. Added 10 newly confirmed as covered and 0 confirmed not covered. Nineteen savings-card offers were deliberately NOT recorded as free-medicine programs -- a copay card is a different thing and does not help someone without insurance.

    Fuente

    Entrada histórica.

  158. Cambio en un programa

    Phoslyra Patient Assistance Program

    Qué cambió

    The Phoslyra Patient Assistance Program appears to no longer exist. We checked the program's own web address and the current owner's medicine list, and it is not there. If you were told about this program, contact the manufacturer directly to ask what replaced it.

    Fuente

    Entrada histórica.

  159. Cambio en un programa

    Jetrea Care

    Qué cambió

    Jetrea Care could not be found. The program's website is no longer in service and the medicine no longer has a company marketing it in the United States. Ask your prescriber about alternatives.

    Fuente

    Entrada histórica.

  160. Cambio en un programa

    Marplan Patient Assistance Program

    Qué cambió

    The Marplan Patient Assistance Program appears to no longer exist. We checked the program's own web address and the current owner's medicine list, and it is not there. If you were told about this program, contact the manufacturer directly to ask what replaced it.

    Fuente

    Entrada histórica.

  161. Cambio en un programa

    Prialt Navigator Reimbursement and Access Program

    Qué cambió

    The Prialt Navigator Reimbursement and Access Program appears to no longer exist. We checked the program's own web address and the current owner's medicine list, and it is not there. If you were told about this program, contact the manufacturer directly to ask what replaced it.

    Fuente

    Entrada histórica.

  162. Cambio en un programa

    Ovation Pharmaceuticals Patient Assistance Program

    Qué cambió

    The Ovation Pharmaceuticals Patient Assistance Program could not be found. Ovation was acquired by Lundbeck, so ask Lundbeck about assistance for the medicine you take.

    Fuente

    Entrada histórica.

  163. Cambio en un programa

    Gelnique Patient Assistance Program

    Qué cambió

    The Gelnique Patient Assistance Program appears to no longer exist. We checked the program's own web address and the current owner's medicine list, and it is not there. If you were told about this program, contact the manufacturer directly to ask what replaced it.

    Fuente

    Entrada histórica.

  164. Cambio en un programa

    Menomune Patient Assistance Program

    Qué cambió

    The Menomune Patient Assistance Program appears to no longer exist. We checked the program's own web address and the current owner's medicine list, and it is not there. If you were told about this program, contact the manufacturer directly to ask what replaced it.

    Fuente

    Entrada histórica.

  165. Cambio en un programa

    Provigil Patient Assistance Program

    Qué cambió

    The Provigil Patient Assistance Program appears to no longer exist. We checked the program's own web address and the current owner's medicine list, and it is not there. If you were told about this program, contact the manufacturer directly to ask what replaced it.

    Fuente

    Entrada histórica.

  166. Cambio en un programa

    Gate Patient Assistance Program

    Qué cambió

    The Gate Patient Assistance Program appears to no longer exist. We checked the program's own web address and the current owner's medicine list, and it is not there. If you were told about this program, contact the manufacturer directly to ask what replaced it.

    Fuente

    Entrada histórica.

  167. Cambio en un programa

    Medicis Patient Assistance Program

    Qué cambió

    The Medicis Patient Assistance Program appears to no longer exist. We checked the program's own web address and the current owner's medicine list, and it is not there. If you were told about this program, contact the manufacturer directly to ask what replaced it.

    Fuente

    Entrada histórica.

  168. Cambio en un programa

    Dendreon On Call PROVENGE Patient Assistance Program

    Qué cambió

    Added the Dendreon On Call program for PROVENGE. Dendreon's own page says PROVENGE may be provided free of cost to uninsured patients, and to patients whose insurance will not cover it, with an income limit of $225,000.

    Fuente

    Entrada histórica.

  169. Cambio en el registro

    Qué cambió

    Harrow Eye, LLC does not run a patient assistance program that gives medicine free based on income. We checked its own website. Where it offers help, that help is a savings or rebate card, which does not help someone without insurance.

    Fuente

    Entrada histórica.

  170. Cambio en el registro

    Qué cambió

    Lupin Pharmaceuticals, Inc. does not run a patient assistance program that gives medicine free based on income. We checked its own website. Where it offers help, that help is a savings or rebate card, which does not help someone without insurance.

    Fuente

    Entrada histórica.

  171. Cambio en el registro

    Qué cambió

    Sebela Pharmaceuticals Inc. does not run a patient assistance program that gives medicine free based on income. We checked its own website. Where it offers help, that help is a savings or rebate card, which does not help someone without insurance.

    Fuente

    Entrada histórica.

  172. Cambio en el registro

    Qué cambió

    Mayne Pharma does not run a patient assistance program that gives medicine free based on income. We checked its own website. Where it offers help, that help is a savings or rebate card, which does not help someone without insurance.

    Fuente

    Entrada histórica.

  173. Cambio en el registro

    Qué cambió

    CMP Pharma, Inc. does not run a patient assistance program that gives medicine free based on income. We checked its own website. Where it offers help, that help is a savings or rebate card, which does not help someone without insurance.

    Fuente

    Entrada histórica.

  174. Cambio en el registro

    Qué cambió

    Medimetriks Pharmaceuticals, Inc. does not run a patient assistance program that gives medicine free based on income. We checked its own website. Where it offers help, that help is a savings or rebate card, which does not help someone without insurance.

    Fuente

    Entrada histórica.

  175. Cambio en el registro

    Qué cambió

    Apotex Corp. does not run a patient assistance program that gives medicine free based on income. We checked its own website. Where it offers help, that help is a savings or rebate card, which does not help someone without insurance.

    Fuente

    Entrada histórica.

  176. Cambio en el registro

    Qué cambió

    Almatica Pharma LLC does not run a patient assistance program that gives medicine free based on income. We checked its own website. Where it offers help, that help is a savings or rebate card, which does not help someone without insurance.

    Fuente

    Entrada histórica.

  177. Cambio en el registro

    Qué cambió

    B. Braun Medical Inc. does not run a patient assistance program that gives medicine free based on income. We checked its own website. Where it offers help, that help is a savings or rebate card, which does not help someone without insurance.

    Fuente

    Entrada histórica.

  178. Cambio en el registro

    Qué cambió

    Bavarian Nordic A/S does not run a patient assistance program that gives medicine free based on income. We checked its own website. Where it offers help, that help is a savings or rebate card, which does not help someone without insurance.

    Fuente

    Entrada histórica.

  179. Cambio en el registro

    Qué cambió

    Rosemont Pharmaceuticals LLC does not run a patient assistance program that gives medicine free based on income. We checked its own website. Where it offers help, that help is a savings or rebate card, which does not help someone without insurance.

    Fuente

    Entrada histórica.

  180. Cambio en el registro

    Qué cambió

    Perfero Pharma, Inc. does not run a patient assistance program that gives medicine free based on income. We checked its own website. Where it offers help, that help is a savings or rebate card, which does not help someone without insurance.

    Fuente

    Entrada histórica.

  181. Cambio en el registro

    Qué cambió

    PANGEA PHARMACEUTICALS, LLC does not run a patient assistance program that gives medicine free based on income. We checked its own website. Where it offers help, that help is a savings or rebate card, which does not help someone without insurance.

    Fuente

    Entrada histórica.

  182. Cambio en el registro

    Qué cambió

    IPG Pharmaceuticals, inc. does not run a patient assistance program that gives medicine free based on income. We checked its own website. Where it offers help, that help is a savings or rebate card, which does not help someone without insurance.

    Fuente

    Entrada histórica.

  183. Cambio en el registro

    Qué cambió

    Noven Therapeutics, LLC does not run a patient assistance program that gives medicine free based on income. We checked its own website. Where it offers help, that help is a savings or rebate card, which does not help someone without insurance.

    Fuente

    Entrada histórica.

  184. Cambio en el registro

    Qué cambió

    Daraprim's assistance program is now run by Tilde Sciences, not Vyera. We updated who to contact.

    Fuente

    Entrada histórica.

  185. Cambio en el registro

    Qué cambió

    EpiPen4Schools is run by Viatris with Bioridge Pharma. Note this program supplies schools, not individual patients -- if you need an EpiPen for yourself, ask about Viatris's patient assistance program instead.

    Fuente

    Entrada histórica.

  186. Cambio en un programa

    horizoncares.com

    Qué cambió

    The horizoncares.com could not be found. Its web address returns a 'site not found' placeholder page. If you were referred to it, ask Amgen's Safety Net Foundation what covers your medicine now.

    Fuente

    Entrada histórica.

  187. Cambio en un programa

    krystexxaconnexxions.com

    Qué cambió

    The krystexxaconnexxions.com could not be found. Its web address no longer answers at all. If you were referred to it, ask Amgen's Safety Net Foundation what covers your medicine now.

    Fuente

    Entrada histórica.

  188. Cambio en un programa

    The COMPASS Program" (no confirmed domain)

    Qué cambió

    The The COMPASS Program" (no confirmed domain) could not be found. We could not find any web address for it, and none of the seven medicines' own sites mention it. If you were referred to it, ask Amgen's Safety Net Foundation what covers your medicine now.

    Fuente

    Entrada histórica.

  189. Cambio en un programa

    Amgen Safety Net Foundation

    Qué cambió

    Seven medicines Amgen acquired with Horizon (Actimmune, Buphenyl, Krystexxa, Procysbi, Ravicti, Tepezza, Uplizna) are not on the Amgen Safety Net Foundation's list, and no separate Horizon program covers them any more -- the old Horizon Cares and Krystexxa Connexxions websites are gone. Each medicine's own site offers a support-and-navigation service called Amgen By Your Side, which helps you get started but does not supply the medicine free. If you cannot afford one of these, ask the prescriber about an independent charity fund.

    Fuente

    Entrada histórica.

  190. Cambio en el registro

    Qué cambió

    Trodelvy is now handled by Gilead, which acquired Immunomedics. Gilead Oncology Support says it may provide Trodelvy free of charge to eligible patients who do not have insurance.

    Fuente

    Entrada histórica.

  191. Cambio en un programa

    AmplifyAssist

    Qué cambió

    Added AmplifyAssist. The program's own page says eligible patients can get the medicine at no cost; we quote that sentence and link to the page we read.

    Fuente

    Entrada histórica.

  192. Cambio en un programa

    Arcutis Cares Patient Assistance Program

    Qué cambió

    Added Arcutis Cares Patient Assistance Program. The program's own page says eligible patients can get the medicine at no cost; we quote that sentence and link to the page we read.

    Fuente

    Entrada histórica.

  193. Cambio en un programa

    Fennec HEARS

    Qué cambió

    Added Fennec HEARS. The program's own page says eligible patients can get the medicine at no cost; we quote that sentence and link to the page we read.

    Fuente

    Entrada histórica.

  194. Cambio en un programa

    ILUVIEN Patient Assistance Program

    Qué cambió

    Added ILUVIEN Patient Assistance Program. The program's own page says eligible patients can get the medicine at no cost; we quote that sentence and link to the page we read.

    Fuente

    Entrada histórica.

  195. Cambio en un programa

    Krystal Connect

    Qué cambió

    Added Krystal Connect. The program's own page says eligible patients can get the medicine at no cost; we quote that sentence and link to the page we read.

    Fuente

    Entrada histórica.

  196. Cambio en un programa

    KURA RxKONNECT

    Qué cambió

    Added KURA RxKONNECT. The program's own page says eligible patients can get the medicine at no cost; we quote that sentence and link to the page we read.

    Fuente

    Entrada histórica.

  197. Cambio en un programa

    Patient Assistance Solutions Program for Letairis

    Qué cambió

    Added Patient Assistance Solutions Program for Letairis. The program's own page says eligible patients can get the medicine at no cost; we quote that sentence and link to the page we read.

    Fuente

    Entrada histórica.

  198. Cambio en un programa

    AccessCubicin Program

    Qué cambió

    The AccessCubicin Program could not be found. Cubicin is not on Merck's current list of medicines its assistance program covers. Merck runs one combined program, so check its current list rather than looking for a Cubicin-specific program.

    Fuente

    Entrada histórica.

  199. Cambio en un programa

    AccessSivextro Program

    Qué cambió

    The AccessSivextro Program could not be found. Sivextro is not on Merck's current list of medicines its assistance program covers. Merck runs one combined program, so check its current list rather than looking for a Sivextro-specific program.

    Fuente

    Entrada histórica.

  200. Cambio en un programa

    Amevive Start Assistance Program

    Qué cambió

    The Amevive Start Assistance Program could not be found. Fetched amevive.com directly -- the domain is a PARKED page ('amevive.com for sale', NamePros parking service iframe), confirming the manufacturer no longer operates this site. Consistent with Amevive (alefacept) having been withdrawn from the US market circa

    Fuente

    Entrada histórica.

  201. Cambio en un programa

    Angiomax Patient Financial Assistance Program

    Qué cambió

    The Angiomax Patient Financial Assistance Program could not be found. angiomax.com resolves in DNS but serves only a default/placeholder Azure App Service page (TLS certificate is a generic *.azurewebsites.net wildcard, not a real angiomax.com cert; no actual site content returned) -- effectively a dead/unmaintained domain, not

    Fuente

    Entrada histórica.

  202. Cambio en un programa

    AstraZeneca Cancer Support Network (AZ CSN)

    Qué cambió

    The AstraZeneca Cancer Support Network (AZ CSN) could not be found. azcancersupportnetwork.com redirects to parkedpage.astrazeneca.com displaying an explicit 'Website Decommissioned' notice on AstraZeneca's own domain -- clean defunct verdict, no successor domain needed since AstraZeneca states it directly.

    Fuente

    Entrada histórica.

  203. Cambio en un programa

    Axcan ASSIST Program

    Qué cambió

    The Axcan ASSIST Program could not be found. axcan.com has no DNS. Axcan Pharma's corporate lineage fragmented across multiple current owners (became Aptalis in 2011 -- also dead domain -- then acquired piecemeal by Forest Labs/Actavis/Allergan in 2014, with individual legacy products dispersed to differ

    Fuente

    Entrada histórica.

  204. Cambio en un programa

    Axcan Rx Cost Reduction Program

    Qué cambió

    The Axcan Rx Cost Reduction Program could not be found. Same defunct verdict and reasoning as the Axcan ASSIST Program entry -- both legacy Axcan-branded programs, dead domain, fragmented corporate successor chain with no single findable live program.

    Fuente

    Entrada histórica.

  205. Cambio en un programa

    Azilect Patient Assistance Program

    Qué cambió

    The Azilect Patient Assistance Program could not be found. azilect.com resolves only to a static prescribing-information PDF with no working PAP portal or enrollment page; teva.com itself returned HTTP 403. Azilect (rasagiline) has been generic/off-patent for years and Teva does not appear to run an active branded PAP

    Fuente

    Entrada histórica.

  206. Cambio en un programa

    Beach Pharmaceuticals

    Qué cambió

    The Beach Pharmaceuticals could not be found. Company itself is alive and its official site is live, but the current site (fetched in full) has no mention whatsoever of any patient assistance program, copay card, or savings program -- its current portfolio (magnesium oxide, sodium phosphate, potassium pho

    Fuente

    Entrada histórica.

  207. Cambio en un programa

    Campath Distribution Program

    Qué cambió

    The Campath Distribution Program could not be found. Campath (alemtuzumab) was voluntarily withdrawn from commercial sale by Genzyme in Sept 2012 specifically to force transition to the much higher-priced MS drug Lemtrada; the Campath Distribution Program provided the drug free to CLL patients only as a bridge d

    Fuente

    Entrada histórica.

  208. Cambio en un programa

    Celltech Patient Assistance Program

    Qué cambió

    The Celltech Patient Assistance Program could not be found. Confirmed UCB acquired Celltech in 2004 (SEC filing, Guardian). Celltech's notable US products (Metadate CD, Sarafem) are long since genericized and neither appears on UCB's current PAP/co-pay scope (Bimzelx, Briviact, Cimzia, Nayzilam, Neupro -- all modern UC

    Fuente

    Entrada histórica.

  209. Cambio en un programa

    Cenestin Patient Assistance Program

    Qué cambió

    The Cenestin Patient Assistance Program could not be found. GoodRx explicitly states Cenestin (synthetic conjugated estrogens) is no longer available in the United States -- the drug itself has been discontinued, not merely the PAP. Clean defunct verdict; no successor product or program to trace since the drug no longe

    Fuente

    Entrada histórica.

  210. Cambio en un programa

    Cephalon Patient Assistance Program

    Qué cambió

    The Cephalon Patient Assistance Program could not be found. Teva acquired Cephalon in 2011. A contemporaneous report confirms Cephalon separately closed its own Provigil Patient Assistance Program years ago. Teva Cares Foundation's current medicines list (fetched directly) is AJOVY, AUSTEDO/AUSTEDO XR, Proglycem, UZEDY

    Fuente

    Entrada histórica.

  211. Cambio en un programa

    Cetylite Industries, Inc

    Qué cambió

    The Cetylite Industries, Inc could not be found. Cetylite Industries is still an active company (cetylite.com live), manufacturing dental/medical topical anesthetics (Cetacaine) sold to practices rather than retail-dispensed prescriptions. Fetched cetylite.com homepage directly -- no mention anywhere on the

    Fuente

    Entrada histórica.

  212. Cambio en un programa

    Cetylite Patient Assistance Program

    Qué cambió

    The Cetylite Patient Assistance Program could not be found. Same underlying company/finding as 'Cetylite Industries, Inc' entry above -- two directory listings (RxHope) for the same manufacturer's PAP. Cetylite's own current site has no patient assistance program page or mention. Verdict: defunct.

    Fuente

    Entrada histórica.

  213. Cambio en un programa

    Cytogen Corp. Community Access Patient Program

    Qué cambió

    The Cytogen Corp. Community Access Patient Program could not be found. Cytogen Corporation (maker of ProstaScint) was acquired by EUSA Pharma in 2010; EUSA was later acquired by Jazz Pharmaceuticals (2019) and subsequently spun back out independently. cytogen.com now redirects to a generic '/lander' domain-parking page. No succes

    Fuente

    Entrada histórica.

  214. Cambio en un programa

    Diplomat's Co-Pay Assistance Navigator Program

    Qué cambió

    The Diplomat's Co-Pay Assistance Navigator Program could not be found. Diplomat Pharmacy was acquired by UnitedHealth's OptumRx in 2020. The named 'Co-Pay Assistance Navigator Program' as a standalone Diplomat entity no longer exists; it has been absorbed into Optum's generic 'Savings IQ' financial-assistance concierge, which its

    Fuente

    Entrada histórica.

  215. Cambio en un programa

    Duexis Savings Plus Program

    Qué cambió

    The Duexis Savings Plus Program could not be found. The drug itself (Duexis) was discontinued by Horizon Therapeutics as a business decision (confirmed via empr.com/FDA Drug Shortages tracker); Teva's generic version was also discontinued. Horizon Therapeutics itself was subsequently acquired by Amgen (2023). N

    Fuente

    Entrada histórica.

  216. Cambio en un programa

    Elan Medical Needs Program

    Qué cambió

    The Elan Medical Needs Program could not be found. Elan Corporation's branded pharma pipeline (e.g. Tysabri rights) was sold off to Biogen/others prior to Perrigo's 2013 acquisition of the remaining Elan corporate shell (for tax/domicile purposes, not a pharma-operations continuation). elan.com now redirects t

    Fuente

    Entrada histórica.

  217. Cambio en un programa

    Eldepryl Patient Rewards Program

    Qué cambió

    The Eldepryl Patient Rewards Program could not be found. Eldepryl (selegiline) is a decades-old brand now available generically; the original brand manufacturer Somerset Pharmaceuticals no longer exists as that company. The domain somersetpharma.com currently resolves to an unrelated, unaffiliated generic-injectable

    Fuente

    Entrada histórica.

  218. Cambio en un programa

    Enzon Patient Assistance Program

    Qué cambió

    The Enzon Patient Assistance Program could not be found. Enzon Pharmaceuticals divested its drug portfolio years ago and became a royalty/shell company; per SEC filings and press (biospace.com, otcmarkets.com), Enzon completed a merger with Viskase Companies Inc. (an unrelated food-packaging firm) around March 2026,

    Fuente

    Entrada histórica.

  219. Cambio en un programa

    Episil Patient Assistance Program

    Qué cambió

    The Episil Patient Assistance Program could not be found. Episil (oral mucositis liquid, medical device classification in the US) was developed by Camurus AB; Solasia Pharma acquired the episil oral liquid business in 2022. No current PAP page found for Episil under either Camurus or Solasia; episil.com is unreachabl

    Fuente

    Entrada histórica.

  220. Cambio en un programa

    Gelnique Patient Assistance Program

    Qué cambió

    The Gelnique Patient Assistance Program could not be found. Per drugs.com generic-availability page: 'Gelnique is a brand name of oxybutynin, All of the above formulations have been discontinued.' gelnique.com does not resolve. No current PAP possible for a discontinued brand. Verdict: defunct.

    Fuente

    Entrada histórica.

  221. Cambio en un programa

    Enjuvia Patient Assistance Program

    Qué cambió

    The Enjuvia Patient Assistance Program could not be found. Enjuvia (originally Duramed/Barr, later Teva) is confirmed discontinued: 'Enjuvia is currently not available in the United States' (GoodRx); manufacturer (Teva) discontinued it with no stated reason. No PAP can exist for a discontinued/unavailable drug. Verdic

    Fuente

    Entrada histórica.

  222. Cambio en un programa

    Entereg Access Support and Education (E.A.S.E.)

    Qué cambió

    The Entereg Access Support and Education (E.A.S.E.) could not be found. FDA Federal Register notice confirms Cubist Pharmaceuticals withdrew NDA approval for Entereg (alvimopan) in 2024: 'Cubist has informed FDA that ENTEREG (alvimopan) Capsules, 12 mg is no longer marketed.' E.A.S.E. was a hospital-facing REMS/stocking program (n

    Fuente

    Entrada histórica.

  223. Cambio en un programa

    GTX Patient Assistance Program

    Qué cambió

    The GTX Patient Assistance Program could not be found. gtxinc.com now resolves to an unrelated health/biotech news blog (most recent article July 2022, no corporate information, no patient programs, no contact info for an operating pharma company) -- the domain has been abandoned/repurposed, not maintained by any

    Fuente

    Entrada histórica.

  224. Cambio en un programa

    hHyalgan Reimbursement Services and Patient Assistance Program

    Qué cambió

    The hHyalgan Reimbursement Services and Patient Assistance Program could not be found. Hyalgan (sodium hyaluronate injection for knee osteoarthritis) is a legacy 1990s-2000s-era product; pfizer.com/products/hyalgan returned 404 and no current manufacturer product page could be located within time budget. This class of hyaluronic-acid knee inject

    Fuente

    Entrada histórica.

  225. Cambio en un programa

    Impax Patient Assistance Program

    Qué cambió

    The Impax Patient Assistance Program could not be found. Impax Laboratories completed its merger with Amneal Pharmaceuticals in 2018 (confirmed via Amneal investor press release). impaxrx.com (a plausible-looking URL) is an unrelated employer cost-management company, not the drug manufacturer's PAP. Rytary and Zomig

    Fuente

    Entrada histórica.

  226. Cambio en un programa

    Interconnect Support Services

    Qué cambió

    The Interconnect Support Services could not be found. CONFIRMED DEFUNCT with direct evidence -- own site banner states voluntary market withdrawal and support ending 12/31/25 (already past as of this 08/20/26 pass). Exactly the kind of stale directory listing the brief warned about.

    Fuente

    Entrada histórica.

  227. Cambio en un programa

    IVAX Patient Assistance Program for Clozapine

    Qué cambió

    The IVAX Patient Assistance Program for Clozapine could not be found. IVAX Pharmaceuticals was acquired by Teva in 2006 (20 years ago) -- 'IVAX' as a standalone operator no longer exists. The program's own referenced site (clozapineregistry.com) timed out on fetch, consistent with an abandoned/legacy domain. Current clozapine PA

    Fuente

    Entrada histórica.

  228. Cambio en un programa

    Jetrea Care

    Qué cambió

    Jetrea Care could not be found. The program's website is no longer in service and the medicine no longer has a company marketing it in the United States. Ask your prescriber about alternatives.

    Fuente

    Entrada histórica.

  229. Cambio en un programa

    Keryx Patient Plus Program

    Qué cambió

    The Keryx Patient Plus Program could not be found. Keryx Biopharmaceuticals merged into Akebia Therapeutics in Dec 2018; the 'Keryx Patient Plus Program' name is defunct. Auryxia's current patient site (auryxia.com/patient-support) now references 'AkebiaCares' as the successor support resource, not 'Keryx Pati

    Fuente

    Entrada histórica.

  230. Cambio en un programa

    Makena Patient Assistance Program

    Qué cambió

    The Makena Patient Assistance Program could not be found. Confirmed via makena.com: FDA ordered withdrawal of Makena's approval effective April 6, 2023 ('On April 6, 2023, the U.S. Food and Drug Administration (FDA) issued a final decision ordering the withdrawal of the approval of Makena'). No active patient assista

    Fuente

    Entrada histórica.

  231. Cambio en un programa

    McNeil Consumer and Specialty Pharmaceuticals PAP

    Qué cambió

    The McNeil Consumer and Specialty Pharmaceuticals PAP could not be found. McNeil Consumer & Specialty Pharmaceuticals was a J&J operating division; its consumer/Rx PAP functions were consolidated into the Johnson & Johnson Patient Assistance Foundation years ago. jjpaf.org connection failed (ECONNREFUSED) during this session. No ope

    Fuente

    Entrada histórica.

  232. Cambio en un programa

    Medicis Patient Assistance Program

    Qué cambió

    The Medicis Patient Assistance Program could not be found. Medicis Pharmaceutical was acquired by Valeant Pharmaceuticals in 2012; Valeant later became Bausch Health. bauschhealth.com/patients/patient-assistance 404'd. No standalone 'Medicis Patient Assistance Program' exists any longer under that name -- any legacy M

    Fuente

    Entrada histórica.

  233. Cambio en un programa

    Menomune Patient Assistance Program

    Qué cambió

    The Menomune Patient Assistance Program could not be found. Menomune (Sanofi Pasteur's older polysaccharide meningococcal vaccine) was discontinued by Sanofi around 2017-2018 in favor of the conjugate vaccine Menveo/Menactra generation of products. needymeds.org detail-page URL guesses 404'd; rxhope not reachable. No o

    Fuente

    Entrada histórica.

  234. Cambio en un programa

    Mito Assist

    Qué cambió

    The Mito Assist could not be found. Confirmed corporate rebrand: mightytx.com homepage states 'Stealth BioTherapeutics is now Mighty Therapeutics.' 'Mito Assist' as a named program does not appear anywhere on the current site; the only patient-access-adjacent program found is an Expanded Access

    Fuente

    Entrada histórica.

  235. Cambio en un programa

    MS One to One Patient Assistance Program

    Qué cambió

    The MS One to One Patient Assistance Program could not be found. mymsaa.org/ms-one-to-one/ 301-redirects to the MSAA nonprofit homepage, which makes no mention of 'MS One to One' or Sanofi Genzyme anywhere. Sanofi Patient Connection's own homepage also does not reference the program or MS drugs by name. Rejected all seven o

    Fuente

    Entrada histórica.

  236. Cambio en un programa

    Mylan Miacalcin Injection Patient Assistance Program

    Qué cambió

    The Mylan Miacalcin Injection Patient Assistance Program could not be found. Miacalcin is NOT on Viatris's current 23-medicine PAP list (verified by fetching the live list), unlike Clozapine/EMSAM/Epinephrine which are all still present. Miacalcin (calcitonin-salmon) has been in market/clinical decline for years as newer osteoporosis d

    Fuente

    Entrada histórica.

  237. Cambio en un programa

    Nabi Patient Assistance Program

    Qué cambió

    The Nabi Patient Assistance Program could not be found. nabi.com connection refused (domain not serving a site). Nabi Biopharmaceuticals divested its biologics business and became Biota Pharmaceuticals in 2012 (later merged into Aviragen, then Vaxart) -- well-documented defunct entity. No successor operates a 'Nabi

    Fuente

    Entrada histórica.

  238. Cambio en un programa

    Nexavar Reach Program

    Qué cambió

    The Nexavar Reach Program could not be found. nexavar-us.com/patient-assistance redirects (301) directly to a raw prescribing-information PDF, not a support page -- strong evidence the branded 'Reach Program' page has been retired. Could not confirm (bayer.com/en/us/patient-assistance-foundation returned

    Fuente

    Entrada histórica.

  239. Cambio en un programa

    Niche Pharmaceuticals Sample Program

    Qué cambió

    The Niche Pharmaceuticals Sample Program could not be found. nichepharm.com resolves to an unrelated Indian contract injectable manufacturer (Nichepharm Lifesciences), not a US retail pharma company with a patient sample program. No current US 'Niche Pharmaceuticals' patient program located. Time-boxed conclusion -- did

    Fuente

    Entrada histórica.

  240. Cambio en un programa

    Neocate Assistance Program (NAP)

    Qué cambió

    The Neocate Assistance Program (NAP) could not be found. No candidate match. Fetched neocate.com and neocate.com/reimbursement directly: no mention anywhere of a 'Neocate Assistance Program' or free-product PAP by that name. Current support offering is 'Nutricia Navigator', described as insurance-navigation help ('p

    Fuente

    Entrada histórica.

  241. Cambio en un programa

    NitroMed Cares Uninsured Patient Program

    Qué cambió

    The NitroMed Cares Uninsured Patient Program could not be found. nitromed.com DNS lookup failed (domain does not resolve). NitroMed Inc. (maker of BiDil) is a well-documented defunct company that wound down / was absorbed after BiDil's weak commercial performance following its 2005 approval. No current successor program exi

    Fuente

    Entrada histórica.

  242. Cambio en un programa

    Novantrone Patient Assistance Program

    Qué cambió

    The Novantrone Patient Assistance Program could not be found. No live official Novantrone site, manufacturer patient-support page, or PAP could be located (novantrone.com empty, drugs.com 403-blocked, Wikipedia confirms Novantrone as a historic trade name for mitoxantrone with no current consumer program listed). Combine

    Fuente

    Entrada histórica.

  243. Cambio en un programa

    Orange Card

    Qué cambió

    The Orange Card could not be found. orangecard.com does not resolve (DNS failure); theorangecard.com redirects live to a GoDaddy parked/for-sale page, confirming the domain is not in active use. NeedyMeds detail page 404'd. No live official site found -- recorded as defunct based on the parked-d

    Fuente

    Entrada histórica.

  244. Cambio en un programa

    Ovation Pharmaceuticals Patient Assistance Program

    Qué cambió

    The Ovation Pharmaceuticals Patient Assistance Program could not be found. Ovation was acquired by Lundbeck, so ask Lundbeck about assistance for the medicine you take.

    Fuente

    Entrada histórica.

  245. Cambio en un programa

    Oxandrin Reimbursement and Patient Assistance Program

    Qué cambió

    The Oxandrin Reimbursement and Patient Assistance Program could not be found. FDA withdrew approval of the branded OXANDRIN (oxandrolone) tablets NDA on June 28, 2023, per Gemini US's voluntary withdrawal request, and simultaneously withdrew four generic ANDAs (Upsher-Smith, Par Pharmaceutical, Sandoz) -- evidence: horizonblue.com legal

    Fuente

    Entrada histórica.

  246. Cambio en un programa

    Pernix Therapeutics Patient Assistance Program

    Qué cambió

    The Pernix Therapeutics Patient Assistance Program could not be found. The company went through bankruptcy and its medicines were sold to other companies, so assistance now depends on whoever owns your medicine today. Ask your pharmacist who makes it, then contact that company.

    Fuente

    Entrada histórica.

  247. Cambio en un programa

    Picato Co-Pay Program

    Qué cambió

    The Picato Co-Pay Program could not be found. Picato itself was withdrawn from the market after a safety review, so there is no longer a medicine for this program to cover. Ask your prescriber about other treatments for the same condition.

    Fuente

    Entrada histórica.

  248. Cambio en un programa

    Purdue Pharma Patient Assistance Program

    Qué cambió

    The Purdue Pharma Patient Assistance Program could not be found. Purdue Pharma (OxyContin) filed for Chapter 11 bankruptcy in 2019 amid the national opioid litigation and has been under a court-supervised restructuring/settlement process since, with its future structure tied up in the opioid settlement trust (Knoa Pharma pr

    Fuente

    Entrada histórica.

  249. Cambio en un programa

    Solvay Pharmaceuticals Patient Assistance Program

    Qué cambió

    The Solvay Pharmaceuticals Patient Assistance Program could not be found. Solvay Pharmaceuticals' pharma business was acquired by Abbott in 2010 (later split into AbbVie in 2013). No standalone 'Solvay Pharmaceuticals Patient Assistance Program' exists today; its legacy drugs (e.g. AndroGel, Creon, Marinol) are already covered under

    Fuente

    Entrada histórica.

  250. Cambio en un programa

    Tanzeum Free Sharps Container Program

    Qué cambió

    The Tanzeum Free Sharps Container Program could not be found. Tanzeum (albiglutide) was voluntarily discontinued/withdrawn from the US market by GSK in 2017-2018 for commercial reasons (not safety). No current sharps-disposal or support program exists for a discontinued drug. Not independently re-verified via fetch given

    Fuente

    Entrada histórica.

  251. Cambio en un programa

    VersaPharm Inc

    Qué cambió

    The VersaPharm Inc could not be found. VersaPharm was acquired by Akorn in 2014. Akorn Inc. filed for bankruptcy twice and permanently ceased US operations/liquidated in 2023 (well-documented industry event, plants closed, FDA registrations withdrawn). No successor patient assistance program identi

    Fuente

    Entrada histórica.

  252. Cambio en un programa

    Xyosted Auto-Injector Disposal Program

    Qué cambió

    The Xyosted Auto-Injector Disposal Program could not be found. Confirmed defunct directly on the manufacturer's own current page -- explicit discontinuation notice.

    Fuente

    Entrada histórica.

  253. Cambio en el registro

    Qué cambió

    Reviewed 716 assistance programs listed in public directories. Where a directory listed one entry per medicine for the same program, we now show a single program instead of many duplicates. Seventy-six of the listings turned out to be savings cards rather than free-medicine programs, and 55 no longer exist.

    Fuente

    Entrada histórica.

  254. Cambio en el registro

    Qué cambió

    Twenty-nine medicines were listed under the wrong manufacturer. R-Pharm US runs a support program for one medicine only (Ixempra), so those listings were corrected to name each medicine's real maker. No medicine was ever shown as covered by the wrong program.

    Fuente

    Entrada histórica.

  255. Cambio en un programa

    CSL Behring Patient Assistance Program

    Qué cambió

    CSL Behring does publish which medicines its support programs cover. We had recorded that it did not, and have corrected that.

    Fuente

    Entrada histórica.

  256. Cambio en el registro

    Qué cambió

    We had recorded that Endo runs a patient assistance program, based on a page about a medicine another company makes. That was wrong, so we no longer claim it. Endo's medicines are being re-checked against Keenova, the company that took over its products.

    Fuente

    Entrada histórica.

  257. Cambio en un programa

    Gilead Advancing Access

    Qué cambió

    Veklury's coverage is based on Gilead's own statement that it runs an assistance program for uninsured patients prescribed Veklury, not on a published list of covered medicines. We relabelled it so the evidence is described accurately.

    Fuente

    Entrada histórica.

  258. Cambio en un programa

    Gilead Support Path

    Qué cambió

    Added Gilead Support Path. The program's own page says eligible patients without insurance coverage can get the medicine at no cost; we quote both that sentence and the eligibility sentence, and link to the page we read.

    Fuente

    Entrada histórica.

  259. Cambio en un programa

    Gilead LEAP (Letairis Education and Access Program)

    Qué cambió

    Added Gilead LEAP (Letairis Education and Access Program). The program's own page says eligible patients without insurance coverage can get the medicine at no cost; we quote both that sentence and the eligibility sentence, and link to the page we read.

    Fuente

    Entrada histórica.

  260. Cambio en un programa

    AccordCares: Udenyca

    Qué cambió

    Added AccordCares: Udenyca. The program's own page says eligible patients without insurance coverage can get the medicine at no cost; we quote both that sentence and the eligibility sentence, and link to the page we read.

    Fuente

    Entrada histórica.

  261. Cambio en un programa

    Eisai Patient Assistance Program: Leqembi

    Qué cambió

    Added Eisai Patient Assistance Program: Leqembi. The program's own page says eligible patients without insurance coverage can get the medicine at no cost; we quote both that sentence and the eligibility sentence, and link to the page we read.

    Fuente

    Entrada histórica.

  262. Cambio en un programa

    BioMarin RareConnections Patient Assistance Program

    Qué cambió

    Added BioMarin RareConnections Patient Assistance Program. The program's own page says eligible patients without insurance coverage can get the medicine at no cost; we quote both that sentence and the eligibility sentence, and link to the page we read.

    Fuente

    Entrada histórica.

  263. Cambio en un programa

    BioMarin RareConnections: Voxzogo

    Qué cambió

    Added BioMarin RareConnections: Voxzogo. The program's own page says eligible patients without insurance coverage can get the medicine at no cost; we quote both that sentence and the eligibility sentence, and link to the page we read.

    Fuente

    Entrada histórica.

  264. Cambio en el registro

    Qué cambió

    Twenty-nine medicines were listed under the wrong manufacturer. R-Pharm US runs a support program for one medicine only (Ixempra), so those listings were corrected to name each medicine's real maker. No medicine was ever shown as covered by the wrong program.

    Fuente

    Entrada histórica.

  265. Cambio en el registro

    Qué cambió

    Twenty-nine medicines were listed under the wrong manufacturer. R-Pharm US runs a support program for one medicine only (Ixempra), so those listings were corrected to name each medicine's real maker. No medicine was ever shown as covered by the wrong program.

    Fuente

    Entrada histórica.

  266. Cambio en un programa

    ACCESS4Me (ROLVEDON)

    Qué cambió

    ROLVEDON's patient assistance program is now run by Assertio Specialty Pharmaceuticals, which took over from Spectrum Pharmaceuticals. Apply to Assertio.

    Fuente

    Entrada histórica.

  267. Cambio en un programa

    Radius Assist (TYMLOS)

    Qué cambió

    Radius Health is now part of Paratek Pharmaceuticals. The Radius Assist program still accepts applications under the Radius Assist name.

    Fuente

    Entrada histórica.

  268. Cambio en un programa

    Gilead Oncology Support (TRODELVY)

    Qué cambió

    TRODELVY patient assistance is handled by Gilead Oncology Support following Gilead's acquisition of Immunomedics. Apply to Gilead Oncology Support.

    Fuente

    Entrada histórica.

  269. Cambio en un programa

    CAPLYTA Patient Assistance Program

    Qué cambió

    Intra-Cellular Therapies is now part of Johnson & Johnson. The CAPLYTA program continues to accept applications directly.

    Fuente

    Entrada histórica.

  270. Cambio en un programa

    ViiV Healthcare Patient Assistance Program

    Qué cambió

    The ViiV Healthcare patient assistance program is operated by the GSK Patient Access Programs Foundation, a separate non-profit. Applications go to the foundation, not to ViiVConnect.

    Fuente

    Entrada histórica.

  271. Cambio en un programa

    AZ&Me Prescription Savings Program

    Qué cambió

    AZ&Me stopped accepting new patients for FARXIGA on May 1, 2026. The program's own homepage states this in its Important Program Updates banner. Patients already enrolled should contact the program directly; the banner speaks only to NEW patients and does not say existing enrollment ends.

    Fuente

    Entrada histórica.

  272. Cambio en un programa

    AZ&Me Prescription Savings Program

    Qué cambió

    AZ&Me stopped accepting new patients for XIGDUO XR on May 1, 2026, per the program's own Important Program Updates banner. Patients already enrolled should contact the program directly; the banner speaks only to NEW patients.

    Fuente

    Entrada histórica.

  273. Cambio en un programa

    AZ&Me Prescription Savings Program

    Qué cambió

    BRILINTA is no longer available through AZ&Me as of January 1, 2026, per the program's own Important Program Updates banner. This is a full withdrawal from the program, not a closure to new patients only.

    Fuente

    Entrada histórica.

  274. Cambio en un programa

    Bristol Myers Squibb Patient Assistance Foundation

    Qué cambió

    ZENBEXUS (iberdomide) is now listed among the medicines available through the Bristol Myers Squibb Patient Assistance Foundation.

    Fuente

    Entrada histórica.

  275. Cambio en un programa

    Bristol Myers Squibb Patient Assistance Foundation

    Qué cambió

    Medicare patients applying to the Bristol Myers Squibb Patient Assistance Foundation must also show they spent at least 3% of their annual household income on out-of-pocket prescription costs in the year they apply. This is in addition to the program's income limits.

    Fuente

    Entrada histórica.

  276. Cambio en un programa

    AR Assist Patient Assistance Program

    Qué cambió

    AR Assist Patient Assistance Program moved its patient page. The link we publish now points to the program's current page.

    Fuente

    Entrada histórica.

  277. Cambio en un programa

    Dompé CONNECT to Care Patient Assistance Program

    Qué cambió

    Dompé CONNECT to Care Patient Assistance Program moved its patient page. The link we publish now points to the program's current page.

    Fuente

    Entrada histórica.

  278. Cambio en un programa

    HEMA Biologics Patient Assistance Program

    Qué cambió

    HEMA Biologics Patient Assistance Program moved its patient page. The link we publish now points to the program's current page.

    Fuente

    Entrada histórica.

  279. Cambio en un programa

    Heron Connect Patient Assistance Program

    Qué cambió

    Heron Connect Patient Assistance Program moved its patient page. The link we publish now points to the program's current page.

    Fuente

    Entrada histórica.

  280. Cambio en un programa

    Impel Pharmaceuticals Patient Assistance Program

    Qué cambió

    Impel Pharmaceuticals Patient Assistance Program moved its patient page. The link we publish now points to the program's current page.

    Fuente

    Entrada histórica.

  281. Cambio en un programa

    CAPLYTA Patient Assistance Program

    Qué cambió

    CAPLYTA Patient Assistance Program moved its patient page. The link we publish now points to the program's current page.

    Fuente

    Entrada histórica.

  282. Cambio en un programa

    Keenova Patient Assistance Program (Acthar Gel, XIAFLEX)

    Qué cambió

    Keenova Patient Assistance Program (Acthar Gel, XIAFLEX) moved its patient page. The link we publish now points to the program's current page.

    Fuente

    Entrada histórica.

  283. Cambio en un programa

    Kyowa Kirin Cares Patient Assistance Program

    Qué cambió

    Kyowa Kirin Cares Patient Assistance Program moved its patient page. The link we publish now points to the program's current page.

    Fuente

    Entrada histórica.

  284. Cambio en un programa

    Carnitor Drug Assistance Program (Leadiant Biosciences, administered by NORD)

    Qué cambió

    Carnitor Drug Assistance Program (Leadiant Biosciences, administered by NORD) moved its patient page. The link we publish now points to the program's current page.

    Fuente

    Entrada histórica.

  285. Cambio en un programa

    Medunik USA Patient Assistance Program (Siklos)

    Qué cambió

    Medunik USA Patient Assistance Program (Siklos) moved its patient page. The link we publish now points to the program's current page.

    Fuente

    Entrada histórica.

  286. Cambio en un programa

    Merz Patient Assistance Program (XEOMIN)

    Qué cambió

    Merz Patient Assistance Program (XEOMIN) moved its patient page. The link we publish now points to the program's current page.

    Fuente

    Entrada histórica.

  287. Cambio en un programa

    Mirum Access Plus Patient Assistance Program

    Qué cambió

    Mirum Access Plus Patient Assistance Program moved its patient page. The link we publish now points to the program's current page.

    Fuente

    Entrada histórica.

  288. Cambio en un programa

    NapoCares Patient Assistance Program

    Qué cambió

    NapoCares Patient Assistance Program moved its patient page. The link we publish now points to the program's current page.

    Fuente

    Entrada histórica.

  289. Cambio en un programa

    VOWST Patient Assistance Program

    Qué cambió

    VOWST Patient Assistance Program moved its patient page. The link we publish now points to the program's current page.

    Fuente

    Entrada histórica.

  290. Cambio en un programa

    Neurocrine Access Support Patient Assistance Program

    Qué cambió

    Neurocrine Access Support Patient Assistance Program moved its patient page. The link we publish now points to the program's current page.

    Fuente

    Entrada histórica.

  291. Cambio en un programa

    NS Support Patient Assistance Program (VILTEPSO)

    Qué cambió

    NS Support Patient Assistance Program (VILTEPSO) moved its patient page. The link we publish now points to the program's current page.

    Fuente

    Entrada histórica.

  292. Cambio en un programa

    OcuCare Patient Assistance Program (DEXTENZA)

    Qué cambió

    OcuCare Patient Assistance Program (DEXTENZA) moved its patient page. The link we publish now points to the program's current page.

    Fuente

    Entrada histórica.

  293. Cambio en un programa

    PTx Assist Patient Assistance Program

    Qué cambió

    PTx Assist Patient Assistance Program moved its patient page. The link we publish now points to the program's current page.

    Fuente

    Entrada histórica.

  294. Cambio en un programa

    PharmaEssentia SOURCE Patient Assistance Program

    Qué cambió

    PharmaEssentia SOURCE Patient Assistance Program moved its patient page. The link we publish now points to the program's current page.

    Fuente

    Entrada histórica.

  295. Cambio en un programa

    PTC Cares Patient Assistance Program

    Qué cambió

    PTC Cares Patient Assistance Program moved its patient page. The link we publish now points to the program's current page.

    Fuente

    Entrada histórica.

  296. Cambio en un programa

    Puma Patient Lynx Patient Assistance Program

    Qué cambió

    Puma Patient Lynx Patient Assistance Program moved its patient page. The link we publish now points to the program's current page.

    Fuente

    Entrada histórica.

  297. Cambio en un programa

    EYLEA4U / myRARE Patient Assistance Program (Regeneron)

    Qué cambió

    EYLEA4U / myRARE Patient Assistance Program (Regeneron) moved its patient page. The link we publish now points to the program's current page.

    Fuente

    Entrada histórica.

  298. Cambio en un programa

    ServierONE Patient Assistance Program

    Qué cambió

    ServierONE Patient Assistance Program moved its patient page. The link we publish now points to the program's current page.

    Fuente

    Entrada histórica.

  299. Cambio en un programa

    SK Life Science Navigator Patient Assistance Program

    Qué cambió

    SK Life Science Navigator Patient Assistance Program moved its patient page. The link we publish now points to the program's current page.

    Fuente

    Entrada histórica.

  300. Cambio en un programa

    SpringWorks CareConnections Patient Assistance Program

    Qué cambió

    SpringWorks CareConnections Patient Assistance Program moved its patient page. The link we publish now points to the program's current page.

    Fuente

    Entrada histórica.

  301. Cambio en un programa

    Taiho Oncology Patient Support Patient Assistance Program

    Qué cambió

    Taiho Oncology Patient Support Patient Assistance Program moved its patient page. The link we publish now points to the program's current page.

    Fuente

    Entrada histórica.

  302. Cambio en un programa

    CAPLYTA Patient Assistance Program

    Qué cambió

    The CAPLYTA patient assistance program now publishes exact income limits by household size, starting at $46,950 for one person and $96,450 for a family of four. Households larger than six add $16,110 per person.

    Fuente

    Entrada histórica.

  303. Cambio en un programa

    Covis Patient Assistance Program

    Qué cambió

    Covis Pharma is now part of Azurity Pharmaceuticals, as stated on the Covis website. The patient assistance program's contact details and phone numbers have not changed.

    Fuente

    Entrada histórica.

  304. Cambio en un programa

    Taiho Oncology Patient Support Patient Assistance Program

    Qué cambió

    Taiho Oncology's patient support program has a new website. The program covers INQOVI, LONSURF and LYTGOBI, and offers free medication to eligible patients who are uninsured or underinsured.

    Fuente

    Entrada histórica.

  305. Cambio en un programa

    Taiho Oncology Patient Support Patient Assistance Program

    Qué cambió

    INQOVI is covered by Taiho Oncology Patient Support's patient assistance program.

    Fuente

    Entrada histórica.

  306. Cambio en un programa

    Taiho Oncology Patient Support Patient Assistance Program

    Qué cambió

    LONSURF is covered by Taiho Oncology Patient Support's patient assistance program.

    Fuente

    Entrada histórica.

  307. Cambio en un programa

    Taiho Oncology Patient Support Patient Assistance Program

    Qué cambió

    LYTGOBI is covered by Taiho Oncology Patient Support's patient assistance program.

    Fuente

    Entrada histórica.

  308. Cambio en un programa

    Pfizer Oncology Together (Pfizer Patient Assistance Program)

    Qué cambió

    Pfizer Oncology Together is now listed. It provides Pfizer oncology medicines at no cost to patients who are uninsured or covered by a government program, with household income up to 300% of the federal poverty level.

    Fuente

    Entrada histórica.

  309. Cambio en un programa

    Pfizer Oncology Together (Pfizer Patient Assistance Program)

    Qué cambió

    Retacrit is covered through Pfizer Oncology Together's patient assistance program.

    Fuente

    Entrada histórica.

  310. Cambio en un programa

    Kaléo Patient Assistance Program

    Qué cambió

    The kaleo patient assistance program publishes its income limit: annual household income under 250% of the federal poverty level, confirmed by your most recent W-2.

    Fuente

    Entrada histórica.

  311. Cambio en un programa

    Medunik USA Patient Assistance Program (Siklos)

    Qué cambió

    The Medunik USA patient assistance program for Siklos publishes its income limit: household income at or below 400% of the federal poverty level.

    Fuente

    Entrada histórica.

  312. Cambio en un programa

    Lilly Cares Foundation Patient Assistance Program

    Qué cambió

    Lilly Cares publishes exact income limits, and they differ by medication group: 300% of the federal poverty level for Group 1 medicines, 400% for Group 2, and 500% for Groups 3 and 4. For one person that is $47,880, $63,840 and $79,800 respectively.

    Fuente

    Entrada histórica.

  313. Cambio en un programa

    Sanofi Patient Connection

    Qué cambió

    Sanofi Patient Connection publishes exact income limits for 2026. In the 48 contiguous states and DC the limit is $63,840 for one person and $132,000 for a family of four. Alaska and Hawaii limits are higher.

    Fuente

    Entrada histórica.

  314. Cambio en un programa

    HealthWell Foundation

    Qué cambió

    HealthWell Foundation has opened a new Oncology Caregiver Behavioral Health Fund.

    Fuente

    Entrada histórica.

  315. Cambio en un programa

    Good Days (Chronic Disease Fund, Inc.)

    Qué cambió

    Good Days' disease funds are now listed individually: 6 are open to new patients, 18 are seeking funds, and 25 are not currently open.

    Fuente

    Entrada histórica.

  316. Cambio en un programa

    The Assistance Fund (TAF)

    Qué cambió

    The Assistance Fund's 47 disease programs that are accepting new patients are now listed individually.

    Fuente

    Entrada histórica.

  317. Cambio en un programa

    The Assistance Fund (TAF)

    Qué cambió

    The Assistance Fund's eligibility rules are now confirmed. You must be a US resident with health insurance, either government-sponsored or private -- the fund does not help uninsured patients. It sets no single income limit; each disease program checks income against your household size.

    Fuente

    Entrada histórica.

  318. Cambio en un programa

    Sanofi CareConnect Patient Assistance Program

    Qué cambió

    Sanofi CareConnect is now listed. It provides certain Sanofi rare-disease therapies at no cost to patients who have no insurance or whose plan will not cover the medicine. Call 1-800-745-4447.

    Fuente

    Entrada histórica.

  319. Cambio en un programa

    Bausch + Lomb Patient Assistance Program

    Qué cambió

    The Bausch + Lomb Patient Assistance Program is now listed. If approved, you can receive your prescribed Bausch + Lomb product at no cost for up to one year. It covers ten eye-care products including MIEBO, XIIDRA, VYZULTA and PROLENSA.

    Fuente

    Entrada histórica.

  320. Cambio en un programa

    CSL Behring Patient Assistance Programs

    Qué cambió

    CSL Behring runs patient assistance programs for people who are uninsured or underinsured. CSL does not publish one list of the medicines they cover; the details sit on each product's own page.

    Fuente

    Entrada histórica.

  321. Cambio en un programa

    Novo Nordisk Patient Assistance Program (PAP)

    Qué cambió

    Wegovy is not on Novo Nordisk's patient assistance program covered-products list, while the diabetes brand Ozempic is covered. A commercial copay card and NovoCare Pharmacy self-pay pricing are listed separately: those are discounts, not charity programs.

    Fuente

    Entrada histórica.

  322. Cambio en un programa

    Lilly Cares Foundation Patient Assistance Program

    Qué cambió

    Mounjaro is not on the Lilly Cares available-medications list; no tirzepatide brand is covered by that program, though Trulicity remains covered. A commercial copay card and flat $499/month LillyDirect self-pay price are listed separately: those are discounts, not charity programs.

    Fuente

    Entrada histórica.

  323. Cambio en un programa

    Lilly Cares Foundation Patient Assistance Program

    Qué cambió

    Zepbound is not on the Lilly Cares available-medications list, for the same reason as Mounjaro: no tirzepatide brand is covered. A commercial copay card, tiered LillyDirect self-pay pricing ($299-$699/month), and a Medicare bridge offer capped at $50/month for Part D patients with a weight-management prescription are listed separately: those are discounts, not charity programs.

    Fuente

    Entrada histórica.

  324. Cambio en el registro

    Qué cambió

    Purdue Pharma permanently ceased operations on 05/01/26. Its successor, Knoa Pharma, runs no patient assistance program: we checked its homepage, patient page and prescriber pages. An older directory site still lists a Purdue assistance program; that listing is out of date.

    Fuente

    Entrada histórica.

  325. Cambio en el registro

    Qué cambió

    The 2025 restructuring split Mallinckrodt into Keenova Therapeutics, which kept Acthar Gel, XIAFLEX, AVEED, EDEX and INOmax, and Par Health USA, which kept generics and injectables. The Acthar assistance program: 700% of the federal poverty level, with income verification, offering Acthar Gel at no cost if you qualify; is run by Keenova, which is who you would apply to. Par Health USA runs no assistance program.

    Fuente

    Entrada histórica.

  326. Cambio en el registro

    Qué cambió

    Endo's XIAFLEX products moved to Keenova Therapeutics, which runs a patient assistance program for them. Keenova is the company you would apply to.

    Fuente

    Entrada histórica.

  327. Cambio en el registro

    Qué cambió

    Aptalis no longer exists as a company. Its surviving products, Zenpep and Viokace, are now Nestle Health Science products, and Nestle runs the Zenpep and Viokace Patient Assistance Program: free medicine in 90-day supplies, with proof of gross monthly household income. Medicare Part D patients below 150% of the federal poverty level also need a denial letter for Medicare Extra Help.

    Fuente

    Entrada histórica.

  328. Cambio en el registro

    Qué cambió

    Strativa Pharmaceuticals was dissolved in May 2015. An older directory site still lists a Strativa assistance program; that listing is out of date. No current company runs one.

    Fuente

    Entrada histórica.

  329. Cambio en el registro

    Qué cambió

    Vertex runs two different kinds of help depending on the brand. For its cystic fibrosis medicines, the program is copay help only: it requires commercial insurance and caps help at $20,000 a year. Separately, JOURNAVX has its own free-medicine program at journavxpap.com for patients who are uninsured or have government insurance, based on income guidelines and income documentation, requiring US residency, with a voucher you redeem at a retail pharmacy.

    Fuente

    Entrada histórica.

  330. Cambio en un programa

    Novartis Patient Assistance Foundation, Inc. (NPAF)

    Qué cambió

    Beginning 07/27/26, NPAF introduced a new online Patient Enrollment Portal for patients who applied for NPAF support on or after that date. Approved patients use it to refill medication; patients with missing documentation use it to upload documents.

    Fuente

    Entrada histórica.

  331. Cambio en un medicamento

    Takeda Help At Hand

    Carbatrol

    Qué cambió

    New patient applications for CARBATROL (carbamazepine) through Takeda Help At Hand are no longer accepted as of 07/01/26. CARBATROL will no longer be available through the program after 12/31/26 (existing patients affected on that later date).

    Fuente

    Entrada histórica.

  332. Cambio en un medicamento

    Takeda Help At Hand

    Rozerem

    Qué cambió

    New patient applications for ROZEREM (ramelteon) through Takeda Help At Hand are no longer accepted as of 07/01/26. ROZEREM will no longer be available through the program after 12/31/26 (existing patients affected on that later date).

    Fuente

    Entrada histórica.

  333. Cambio en un medicamento

    Takeda Help At Hand

    Fosrenol

    Qué cambió

    New patient applications for FOSRENOL (lanthanum carbonate) through Takeda Help At Hand are no longer accepted as of 07/01/26. FOSRENOL will no longer be available through the program after 12/31/26 (existing patients affected on that later date).

    Fuente

    Entrada histórica.

  334. Cambio en un medicamento

    Takeda Help At Hand

    Pentasa

    Qué cambió

    New patient applications for PENTASA (mesalamine (pentasa)) through Takeda Help At Hand are no longer accepted as of 07/01/26. PENTASA will no longer be available through the program after 12/31/26 (existing patients affected on that later date).

    Fuente

    Entrada histórica.

  335. Cambio en un programa

    Endo Pharmaceuticals patient assistance (successor entity)

    Qué cambió

    Endo no longer exists as an operating identity. Mallinckrodt and Endo merged on 07/31/25; the combined company spun off its generics and sterile injectables business as Par Health, and rebranded the specialty therapeutics company as Keenova Therapeutics in November 2025. endo.com now serves only a chooser page directing visitors to keenova.com or parhealth.com. Which successor holds each former Endo brand: and whether either operates a patient assistance program; is unresolved: no fetched primary source states a program name, eligibility criteria or benefit for either successor.

    Fuente

    Entrada histórica.

  336. Cambio en un programa

    Bausch Health Patient Assistance Program

    Qué cambió

    Bausch Health stopped participating in certain federal programs that help cover medications for Medicaid patients, effective 10/01/25. Medicaid plans may no longer cover Bausch Health medications for affected patients. A distinct 'I am on Medicaid and a first-time applicant' PAP application track was created for these patients to get free medication directly through the Patient Assistance Program instead.

    Fuente

    Entrada histórica.

Cobertura y niveles de verificación

510
Verificado con un documento de referencia
443
El fabricante tiene un programa, pero no publica una lista de medicamentos
536
Programa del fabricante sin confirmar
1,609
Información insuficiente

El estado de una ficha no certifica todos sus datos ni cada relación entre un medicamento y un programa. Indicamos los datos que faltan por confirmar. Cómo verificamos la información.

Programas por empresa matriz
Fabricante, número de programas y estado de verificación por empresa matriz
Fabricante Programas Estado
Aadi Bioscience 1 Todos verificados
Abbott Nutrition 1 Todos verificados
AbbVie Inc. 2 Incluye fichas sin verificar
Acadia Pharmaceuticals Inc. 1 Todos verificados
Accord BioPharma 3 Incluye fichas sin verificar
Acorda Therapeutics 1 Incluye fichas sin verificar
Acrotech Biopharma Inc. 1 Todos verificados
Adamas Pharmaceuticals 1 Incluye fichas sin verificar
Adaptimmune 1 Todos verificados
ADC Therapeutics 1 Todos verificados
AGEPHA Pharma USA, LLC 1 Todos verificados
Alcon Laboratories, Inc. (Novartis eye-care spinoff) 1 Todos verificados
Alimera Sciences (ANI Pharmaceuticals) 1 Incluye fichas sin verificar
Alkermes plc 1 Todos verificados
Alnylam Pharmaceuticals 4 Todos verificados
American Regent, Inc. 1 Todos verificados
Amgen Inc. 1 Todos verificados
Amicus Therapeutics, Inc. 2 Todos verificados
Amneal Pharmaceuticals LLC 1 Todos verificados
ANI Pharmaceuticals 1 Incluye fichas sin verificar
Apellis Pharmaceuticals 1 Todos verificados
Arbor Pharmaceuticals, LLC 1 Todos verificados
Arcutis Biotherapeutics 1 Incluye fichas sin verificar
Arna Pharma 1 Todos verificados
Ascendis Pharma 2 Todos verificados
Assertio Specialty Pharmaceuticals, LLC 1 Todos verificados
Astellas Pharma US, Inc. 7 Todos verificados
AstraZeneca Pharmaceuticals LP 1 Todos verificados
Aucta Pharmaceuticals 1 Todos verificados
AVEO Oncology 1 Todos verificados
Azurity Pharmaceuticals, Inc. 2 Incluye fichas sin verificar
Bausch + Lomb Incorporated 1 Todos verificados
Bayer HealthCare LLC 1 Todos verificados
Biocon Biologics 1 Todos verificados
Biogen Inc. 2 Todos verificados
BioMarin Pharmaceutical Inc. 3 Incluye fichas sin verificar
BioRidge Pharma 1 Todos verificados
Blueprint Medicines Corporation 1 Todos verificados
Boehringer Ingelheim Pharmaceuticals, Inc. 1 Todos verificados
BridgeBio Pharma 1 Todos verificados
Bristol-Myers Squibb Company 1 Todos verificados
Catalyst Pharmaceuticals, Inc. 1 Todos verificados
Celltrion USA 7 Todos verificados
chiesi-usa 1 Todos verificados
Chimerix 1 Todos verificados
Coherus Oncology, Inc. 1 Todos verificados
Corcept Therapeutics 1 Incluye fichas sin verificar
Covis Pharma 1 Todos verificados
Crinetics Pharmaceuticals 1 Todos verificados
CSL Behring LLC 2 Todos verificados
Daiichi Sankyo, Inc. 2 Todos verificados
Day One Biopharmaceuticals 1 Todos verificados
Deciphera Pharmaceuticals 2 Todos verificados
Dendreon Pharmaceuticals LLC 1 Incluye fichas sin verificar
Dexcom 1 Todos verificados
Digestive Care, Inc. 1 Todos verificados
Dompé U.S., Inc. 1 Todos verificados
Eisai Inc. 2 Incluye fichas sin verificar
Eli Lilly and Company 1 Todos verificados
EMD Serono, Inc. 4 Incluye fichas sin verificar
Eton Pharmaceuticals, Inc. 1 Todos verificados
Exelixis, Inc. 1 Todos verificados
Fennec Pharmaceuticals Inc. 1 Incluye fichas sin verificar
Ferndale Laboratories, Inc. 1 Todos verificados
Ferring Pharmaceuticals Inc. 1 Todos verificados
Fidia Pharma USA Inc. 1 Todos verificados
Galderma Laboratories, L.P. 1 Todos verificados
Genentech, Inc. (Roche Group) 1 Todos verificados
Gilead Sciences, Inc. 6 Incluye fichas sin verificar
Grifols USA, LLC 2 Todos verificados
GSK plc 2 Todos verificados
H. Lundbeck A/S (US) 1 Todos verificados
HarborPath 1 Todos verificados
Helsinn Therapeutics (U.S.), Inc. 1 Todos verificados
HEMA Biologics, LLC 1 Todos verificados
Heron Therapeutics, Inc. 1 Todos verificados
Immunomedics, Inc. (Gilead Sciences) 1 Todos verificados
Impel Pharmaceuticals Inc. 1 Todos verificados
Incyte Corporation 1 Todos verificados
Intra-Cellular Therapies, Inc. 1 Todos verificados
Ionis Pharmaceuticals, Inc. 1 Todos verificados
Ipsen Biopharmaceuticals, Inc. 2 Todos verificados
ITF Therapeutics 1 Todos verificados
Jazz Pharmaceuticals plc 1 Todos verificados
Johnson & Johnson 1 Todos verificados
K Pharmaceuticals 1 Todos verificados
Kadmon Corporation (Sanofi, 2021 acquisition) 1 Todos verificados
Kaléo, Inc. 1 Todos verificados
kamada 1 Todos verificados
Karyopharm Therapeutics Inc. 1 Todos verificados
Kedrion Biopharma, Inc. 1 Todos verificados
Keenova Therapeutics 1 Todos verificados
Krystal Biotech, Inc. 1 Incluye fichas sin verificar
Kura Oncology, Inc. 1 Incluye fichas sin verificar
Kyowa Kirin, Inc. 1 Todos verificados
Leadiant Biosciences, Inc. 1 Todos verificados
Legacy Pharmaceuticals 1 Todos verificados
LEO Pharma Inc. 3 Todos verificados
Ligand Pharmaceuticals 1 Todos verificados
Medunik USA 2 Incluye fichas sin verificar
Melinta Therapeutics, LLC 1 Todos verificados
Merck & Co., Inc. 1 Todos verificados
Merz North America, Inc. 1 Todos verificados
Mirum Pharmaceuticals, Inc. 1 Todos verificados
Mission Pharmaceutical 1 Incluye fichas sin verificar
Napo Pharmaceuticals, Inc. 1 Todos verificados
National Organization for Rare Disorders 1 Incluye fichas sin verificar
Nestle Health Science 2 Todos verificados
Neurocrine Biosciences, Inc. 1 Todos verificados
Novartis Pharmaceuticals Corporation 1 Todos verificados
Novo Nordisk Inc. 1 Todos verificados
NS Pharma, Inc. 1 Todos verificados
Ocular Therapeutix, Inc. 1 Todos verificados
OPKO Renal, LLC (OPKO Health, Inc.) 1 Todos verificados
Organogenesis Inc. 1 Todos verificados
Otsuka America Pharmaceutical, Inc. 1 Todos verificados
Partner Therapeutics, Inc. 1 Todos verificados
Pfizer Inc. 2 Todos verificados
pharma& GmbH 1 Incluye fichas sin verificar
Pharmacosmos Therapeutics Inc. 1 Todos verificados
PharmaEssentia Corporation 1 Todos verificados
PTC Therapeutics, Inc. 1 Todos verificados
Puma Biotechnology, Inc. 1 Todos verificados
QOL Medical, LLC 1 Todos verificados
R-Pharm US 1 Todos verificados
Radius Health, Inc. 1 Todos verificados
Rayner Surgical, Inc. 1 Todos verificados
Recordati Rare Diseases Inc. 3 Todos verificados
Regeneron Pharmaceuticals, Inc. 2 Todos verificados
Salix Pharmaceuticals (Bausch Health) 1 Todos verificados
Sandoz Inc. (Novartis generics spinoff) 1 Todos verificados
Sanofi 5 Todos verificados
Sanofi Genzyme 1 Todos verificados
Servier Pharmaceuticals LLC 1 Todos verificados
Shionogi Inc. 1 Todos verificados
SK Life Science, Inc. 1 Todos verificados
Smith+Nephew 1 Todos verificados
SpringWorks Therapeutics, Inc. 1 Todos verificados
Stemline Therapeutics, Inc. 1 Todos verificados
Sumitomo Pharma America, Inc. 1 Todos verificados
Sun Pharmaceutical Industries, Inc. 1 Incluye fichas sin verificar
Sunovion Pharmaceuticals Inc. 1 Todos verificados
Supernus Pharmaceuticals, Inc. 2 Todos verificados
Swedish Orphan Biovitrum (Sobi) US Inc. 2 Todos verificados
Taiho Oncology, Inc. 1 Todos verificados
Takeda Pharmaceuticals U.S.A., Inc. 1 Todos verificados
TerSera Therapeutics LLC 1 Todos verificados
Teva Pharmaceuticals USA, Inc. 1 Todos verificados
TG Therapeutics, Inc. 1 Todos verificados
Thea Pharma Inc. 1 Todos verificados
Tolmar Pharmaceuticals, Inc. 1 Incluye fichas sin verificar
UCB Pharma, Inc. 1 Todos verificados
United Therapeutics Corporation 1 Todos verificados
Validus Pharmaceuticals LLC 1 Todos verificados
Vanda Pharmaceuticals Inc. 1 Todos verificados
Veloxis Pharmaceuticals, Inc. 1 Todos verificados
Vera Therapeutics, Inc. 1 Todos verificados
Vertex Pharmaceuticals Incorporated 1 Todos verificados
Viatris Inc. (formerly Mylan) 1 Todos verificados
ViiV Healthcare 1 Todos verificados
VIVUS LLC 1 Todos verificados
Vyera 1 Todos verificados
Waylis Therapeutics LLC 1 Todos verificados
Xeris Pharmaceuticals, Inc. 1 Incluye fichas sin verificar
Zevra Therapeutics 1 Incluye fichas sin verificar

Accede a los datos

El acceso a la API es gratuito mediante solicitud para usos aprobados, incluidos los comerciales y los de organizaciones. El conjunto de datos publicado tiene licencia CC BY 4.0, que permite la reutilización comercial con atribución.

Fuentes supervisadas

224 fuentes de programas en el inventario de supervisión.

Última revisión de datos completada: 09/06/26. Una revisión completada no significa que se haya podido acceder a todas las fuentes ni confirmar todos los datos.

Uso

Aquí no se muestran estadísticas públicas de uso. Nuestra política de privacidad explica qué eventos del sitio, recuentos de búsquedas de medicamentos y datos de análisis recopilamos.